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ABSTRACT
In the first project, a simple, rapid, and reversible fluorescent DNA INHIBIT
logic gate has been developed for sensing mercury (Hg2+) and iodide (I-) ions based on
a molecular beacon (MB). In this logic gate, a mercury ion was introduced as the first
input into the MB logic gate system to assist in the hybridization of the MB with an
assistant DNA probe through the thymine–Hg2+–thymine interaction, which eventually
restored the fluorescence of MB as the output. With this signal-on process, mercury
ions can be detected with a limit of detection as low as 7.9 nM. Furthermore, when
iodide ions were added to the Hg2+/MB system as the second input, the fluorescence
intensity decreased because Hg2+ in the thymine–Hg2+–thymine complex was grabbed
by I- due to a stronger binding force. Iodide ions can be detected with a limit of detection
of 42 nM. Meanwhile, we studied the feasibility and basic performance of the DNA
INHIBIT logic gate, optimized the logic gate conditions, and investigated its sensitivity
and selectivity. The results showed that the MB based logic gate is highly selective and
sensitive for the detection of Hg2+ and I- over other interfering cations and anions.
In the second project, an ultrasensitive and rapid turn-on fluorescence assay
has been developed for the detection of 3’-5’ exonuclease activity of exonuclease III
(Exo III) using molecular beacons (MBs). This method has a linear detection range
from 0.04 to 8.00 U mL-1 with a limit of detection of 0.01 U mL-1. In order to improve
the selectivity of the method, a dual-MB system has been developed to distinguish
between different exonucleases. With the introduction of two differently designed MBs
which respond to different exonucleases, the T5 exonuclease, Exo III and RecJf
exonucleases can be easily distinguished from each other. Furthermore, fetal bovine
xvii

serum and fresh mouse serum were used as complex samples to investigate the
feasibility of the dual-MB system for the detection of the enzymatic activity of Exo III.
As a result, the dual-MB system showed a similar calibration curve for the detection of
Exo III as in the ideal buffer solution. The designed MB probe could be a potential
sensor for the detection of Exo III in biological samples.
In the third project, A sensitive label-free fluorescence assay for monitoring
T4 polynucleotide kinase (T4 PNK) activity and inhibition was developed based on a
coupled λ exonuclease cleavage reaction and SYBR Green I. In this assay, a doublestranded DNA (dsDNA) was stained with SYBR Green I and used as a substrate for T4
PNK. After the 5-́hydroxyl termini of the dsDNA was phosphorylated by the T4 PNK,
the coupled λ exonuclease began to digest the dsDNA to form mononucletides and
single-stranded DNA (ssDNA). At this moment, the fluorescence intensity of the SYBR
Green I decreased because less affinity with ssDNA than dsDNA. The decrease extent
was proportional to the concentration of the T4 PNK. After optimization of the
detection conditions, including the concentration of ATP, amount of λ exonuclease and
reaction time, the activity of T4 PNK was monitored by the fluorescence measurement,
with the limit of detection of 0.11 U/mL and good linear correlation between 0.25-1.00
U/mL (R2=0.9896). In this assay, no label was needed for the fluorescence detection.
Moreover, the inhibition behaviours of the T4 PNK’s inhibitors were evaluated by this
assay. The result indicated a potential of using this assay for monitoring of
phosphorylation-related process.
In the fourth project, a facile bottom-up method for the synthesis of highly
fluorescent graphene quantum dots (GQDs) has been developed using a one-step
pyrolysis of a natural amino acid, L-glutamic acid, with the assistance of a simple
heating mantle device. The developed GQDs showed strong blue, green and red
xviii

luminescence under irradiation with ultra-violet, blue and green light, respectively.
Moreover, the GQDs emitted near-infrared (NIR) fluorescence in the range 800–850
nm with an excitation-dependent manner. This NIR fluorescence has a large Stokes
shift of 455 nm, providing a significant advantage for the sensitive determination and
imaging of biological targets. The fluorescence properties of the GQDs, such as the
quantum yields, fluorescence life times, and photostability, were measured and the
fluorescence quantum yield was as high as 54.5%. The morphology and composites of
the GQDs were characterized using TEM, SEM, EDS, and FT-IR. The feasibility of
using the GQDs as a fluorescent biomarker was investigated through in vitro and in
vivo fluorescence imaging. The results showed that the GQDs could be a promising
candidate for bioimaging. Most importantly, compared to the traditional quantum dots
(QDs), the GQDs are chemically inert. Thus, the potential toxicity of the intrinsic heavy
metal in the traditional QDs would not be a concern for GQDs. In addition, the GQDs
possessed an intrinsic peroxidase-like catalytic activity that was similar to graphene
sheets and carbon nanotubes. Coupled with 2,20-azino-bis(3-ethylbenzothiazoline-6sulphonic acid) (ABTS), the GQDs can be used for the sensitive detection of hydrogen
peroxide with a limit of detection of 20 mM.
In the fifth project, a general, environmental-friendly, one-pot method for the
fabrication of reduced graphene oxide (RGO)/metal (oxide) (e.g. RGO/Au, RGO/Cu2O,
and RGO/Ag) nanocomposties was developed using glucose as the reducing agent and
stabilizer. The RGO/metal (oxide) nanocomposites were characterized using STEM,
FE-SEM, EDS, UV-vis absorption spectroscopy, XRD, FT-IR and Raman spectroscopy.
The reducing agent, glucose, not only reduced GO effectively to RGO, but it also
reduced the metal precursors to form metal (oxide) nanoparticles on the surface of RGO.
Moreover, the RGO/metal (oxide) nanocomposites were stabilized by gluconic acid on
xix

the surface of RGO. Finally, the developed nanomaterials were successfully applied to
simultaneous electrochemical analysis of L-ascorbic acid (L-AA), dopamine (DA) and
uric acid sing RGO/Au nanocomposite as an electrode catalyst.
In the sixth project, a reduced graphene oxide/silver nanoparticle (RGO/Ag)
nanocomposite using glucose as the environmental-friendly reducing agent was
developed. The antibacterial activity of RGO/Ag nanocomposite was carefully
investigated using Escherichia coli (E. coli) and Klebsiella pneumoniae (Kp) as
bacterial models. We found that, compared with AgNPs, graphene oxide (GO) and
RGO, RGO/Ag nanocomposite had higher antibacterial efficiency. Furthermore, under
the near-infrared (NIR) irradiation, RGO/Ag nanocomposite demonstrated enhanced
synergetic antibacterial activity through the photothermal effect. Almost 100 % of E.
coli and Kp were killed by the treatment of 15 µg/mL and 20 µg/mL, respectively, with
NIR irradiation. Moreover, the membrane integrity assay and ROS species assay
demonstrated that RGO/Ag nanocomposite under NIR irradiation caused the cell
membranes disruption and generation of ROS species, providing other possible
mechanisms for their high antibacterial activity besides photothermal effect.
In the seventh project, a rigid distance spacer, silica shell, was used between
GO and dyes in this work to elucidate the quenching ability of GO. First, an organic
dye was doped in silica nanoparticles, followed by the modification of another layer of
silica shell with a different thickness. Due to the electrostatic interaction between GO
and positively charged silica nanoparticles, GO wrapped the silica nanoparticles when
they were mixed together. Therefore, the distance between GO and organic dyes was
adjusted by the thickness of the silica shell. The quenching efficiency of GO to two
different

organic

dyes,

including

Tetramethylrhodamine

(TAMRA)

and

Tris(bipyridine)ruthenium(II) chloride (Rubpy), was measured at various distances.
xx

This quenching ability investigation of GO to dyes with distance-dependent manner
would provide a guideline for the design of the fluorescent functional composite using
GO in the future.
In the eighth project, we characterized the antibacterial activity of GO in both
cell culture and animal models. Klebsiella pneumoniae (Kp) is one of the most common
multidrug resistant (MDR) pathogens in causing persistent nosocomial infections and
is very difficult to eradicate once established in the host. First, we demonstrated that
GO exerted direct killing of Kp in agar dishes and afforded the protection of alveolar
macrophages (AM) from Kp infection in culture. We then evaluated the mortality, tissue
damage,

polymorphonuclear

neutrophil

(PMN)

penetration,

and

bacterial

dissemination in Kp-infected mice. Our results revealed that GO can counteract the
invasive ability of Kp in vivo, resulting in lessened tissue injury, significant but subdued
inflammatory response, and prolonged mouse survival. These findings indicate that GO
may be an alternative agent for controlling MDR pathogens in clinics.
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CHAPTER I
A REVERSIBLE FLUORESCENT LOGIC GATE FOR SENSING MERCURY AND
IODIDE IONS BASED ON A MOLECULAR BEACON
1. Introduction
Molecular Boolean logic gates are advanced microdevices that can perform various
logical operations based on molecules.1 The basic types of Boolean logic gates include
AND, OR, NOT, INHIBIT, NOR, NAND, XOR, and XNOR. The advanced logical
calculation could be performed through combination of these types of logic gates.
Therefore, Boolean logic gate is

promising in the fabrication of molecular

computation,2-4 becoming a potential substitute for the traditional silicon-based
computation.5 Among the molecular Boolean logic gates, DNA-based logic gates have
attracted great attention because of the easy manipulation of DNAs. They could be
fabricated based on various behaviors of DNAs such as hybridization, cleavage and
allosteric regulation.6

A number of DNA based logic gates, including the methods

coupled with graphene oxide as the quencher,7, 8 DNAzyme,3, 9, 10 and aptamers11 were
reported recently. Compared with other molecular logic gates, such as an enzymeinhibitor12 and a small super-molecule system,13 a DNA logic gate shows a number of
advantages. The most significant benefits include low cost, specific genetic information
recognition, simplicity, various input species (e.g., metal ions,14-18 DNA sequences,19-21
small biomolecules,22

and proteins23) and different types of output signals.4, 15, 18, 24

Meanwhile, the excellent selectivity of a DNA probe for its target inputs provides a
promising platform for biosensing applications. For instance, the specific binding of
the thymine-Hg2+-thymine (T-Hg2+-T) and cytosine-Ag+-cytosine (C-Ag+-C) were

1

widely used for the multi-ions detection with fluorescence25 and colorimetric
methods.26 However, most of the fluorescence output-based DNA logic gates were
fabricated through coupling with fluorescence nano-quenchers. For example, graphene
oxides were widely used to fabricate different types of logic gates.16,

22

The

nanomaterials bring complicity to DNA logic gates. In contrast, molecular beaconbased self-quenched DNA logic gates are more feasible.
A molecular beacon (MB) is a designed hairpin-structured DNA strand labeled with
a fluorophore and a quencher at both ends. MBs have been widely used for the
fabrication of different biosensors.27 The high selectivity and sensitivity of the MBbased biosensors are benefitted from its loop-stem structure and low background signal.
Recently, a MB has been used for the fabrication of different types of Boolean logic
gates.28 For example, Park et al. constructed several types of Boolean logic gates using
DNA sequences as inputs.19 The developed logic gates could be operated reversibly and
reset to the original state. Yang et al. developed a half-adder and half-subtractor through
combining a MB-based AND gate and a XOR gate, an INHIBIT gate and a XOR gate,
respectively.29 However, all of these MB based logic gates used DNA sequences as
inputs, which limited their applications.
Herein, a reversible INHIBIT logic gate based on a MB was developed with two
ions as inputs and fluorescence as output for the detection of Hg2+ and I-. Hg2+ is
considered as one of the most hazardous pollutants for human health and environmental
protection.30,

31

The US Environmental Protection Agency (EPA) has a standard

maximum allowable level for Hg2+ of 10 nM in drinking water. Iodide ion is an essential
nutrient for humans. The lack of I- would lead to serious health problems.32, 33 Recently,
several papers reported the sensitive sensing systems for the detection of Hg2+ using
DNA probes. Liu et. al used a thrombin-binding aptamer labeled with a fluorophore and
2

a quencher at its 5’ and 3’ termini to detect Pb2+ and Hg2+ with the detection limit of
300 pM and 5.0 nM, respectively.34 However, this is a turn-off method for the sensing,
which might increase the background signal. Also, several nanomaterials, such as gold
nanoparticles,35 quantum dots,17 carbon nanotubes36 and graphene oxides,7 have been
used for the fabrication of Hg2+ and other ions sensors. These methods have some
limitations, including complicated synthesis of the modified nanomaterials, high cost,
and low stability for the long-time sensing. Therefore, the development of a novel
system for the detection of these two ions is important for human health and
environmental protection.
2. Experimental Section
2.1. Chemicals and Instruments.
DNA sequences used in this work were purchased form Fisher Scientific. The
sequences for MB was: 5’-FAM-CCA CCA GTT TTT TAG CTG AGG GTG G-BHQ1
-3’; and the sequences for an assistant probe was 5’-CCCT CAG CTT AAT AACT-3’.
NiCl2, CaCl2, ZnCl2, CuCl2, MnCl2, CoCl2, Pb(NO3)2, FeCl2 and HgCl2 were purchased
from Sigma-Aldrich (reagent-grade). All experiments were performed in a pH7.4 buffer
solution made of 10 mM Tris-HCl, 50 mM NaCl, and 10 mM MgCl2. The DI water
(18.3 MΩ•cm) was produced from the Millipore water purification system.
All fluorescence experiments were carried out using a Fluorolog-3
Spectrofluorometer with a 450 W xenon lamp (Jonin Yvon-Spex, Instruments S.A.,
Edison, NJ). Both excitation and emission slit widths were set to be 5.0 nm. FAM was
excited at 480 nm with a fluorescence emission range of 500 - 600 nm.
2.2. Investigation of Feasibility of the Logic Gates.
A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL of 100.0 μM assistant MB probe
were mixed in 100.0 μL buffer solution that was incubated at 32 ℃ for 5 min. The final
3

concentrations of MB and the assistant MB probe were 10.0 nM and 200.0 nM,
respectively. Afterwards, 0.2 μL of 100.0 μM Hg2+ was added to the reaction system.
After 5 min of reaction, aliquot of I- was added to the solution to react for 2 min. The
final concentration of I- was 12.8 μM. Fluorescence intensity at 518 nm was monitored
via the function of time.
2.3. Investigation of Reversibility of the Logic Gate.
A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0 μM assistant MB probe and
0.2 μL of 100.0 μM Hg2+ were mixed in a 100.0 μL reaction buffer at 32 ℃ for 5 min,
and then the fluorescence intensity was detected. Then, 0.2 μL of 200.0 μM I- was added
and the fluorescence intensity was monitored within 2 min. Afterwards, 0.2 μL of 100.0
μM Hg2+ was injected again to measure the fluorescence intensity in 5 min. This process
was repeated for two times.
2.4. Detection of Hg2+.
A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL of 100.0 μM assistant MB probe
were added in a 100.0 μL reaction buffer at 32 ℃ for 5 min and recorded the
fluorescence intensity. Different concentrations of Hg2+ were added into the solution.
The Hg2+concentrations were 0, 10, 50, 100, 200, 500 and 1000 nM. After 5 min of the
reaction, the fluorescence intensity of the solution was detected.
The investigation of the selectivity of the MB logic gate over other interfered
metal ions was conducted in a similar way. A 1.0 μL aliquot of 1.0 μM MB and 0.2 μL
of 100.0 μM assistant MB probe were mixed in a 100.0 μL reaction buffer at 32 ℃ for
5 min and the fluorescence intensity was measured. Afterwards, different ions,
including Ni2+, Zn2+, Cu2+, Mn2+, Co2+, and Fe2+, were added into the solution and were
incubated for 5 min. The final concentration of these ions was 1.0 μM. Finally, the
fluorescence intensity of each solution was detected.
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2.5. Detection of I-.
A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0 μM assistant MB probe and
0.2 μL of 100.0 μM Hg2+ were added in a 100.0 μL reaction buffer at 32 ℃ for 5 min
followed by fluorescence intensity measurement. Afterwards, different concentrations
of I- were added to the reaction solution. The concentrations of I- were 0, 0.05, 0.10,
0.20, 0.40, 0.80, 1.60, 3.20, 6.40 and 12.80 μM. After 2 min of the reaction, the
fluorescence intensity was measured.
The investigation of the selectivity of the MB logic gate over other interfered
anions was conducted in a similar way. A 1.0 μL aliquot of 1.0 μM MB, 0.2 μL of 100.0
μM assistant MB probe and 0.2 μL of 100.0 μM Hg2+ were added in a 100.0 μL reaction
buffer at 32 ℃ for 5 min and the fluorescence intensity was recorded. Afterwards,
different anions, including Cl-, Br-, F-, SO42-, ClO3-, HCO3-, HPO4-, NO3-, IO3- and I-,
were added. The final concentration of these ions was 6.40 μM. After 2 min of
incubation the fluorescence intensity of each solution was detected.
3. Results and Discussion
3.1. Design of the Logic Gate.
In this work, we have fabricated a DNA INHIBIT logic gate based on a
molecular beacon (MB) using Hg2+ and I- as inputs and the fluorescence signal as an
output. This logic gate could be used to detect trace amount of Hg2+ and I- as shown
in Scheme 1. A MB has a hairpin structure that induces fluorescence resonance energy
transfer (FRET) between the modified dye and the quencher at each end, showing
fluorescence “off” state. An assistant DNA probe was employed, which had two T-T
mismatch bases when it hybridized with MB. Due to the T-T mismatch, the
hybridization between the MB and the assistant probe was limited. Therefore, the loop
of the MB could not be open, keeping fluorescence “off” status (Scheme 1 A).
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Scheme 1. A schematic illustration of the MB-based INHIBIT logic gate for the sensing
of the Hg2+ and I-.
It has been demonstrated that Hg2+ could conjugate two mismatched thymines
(T) in DNA sequences to form T–Hg2+–T complex.17 The binding constant between T
and Hg2+ is about 106.37 Based on this principle, in our design Hg2+ was chosen as the
first input. In the presence of Hg2+, the mismatched assistant DNA probe could easily
hybridize with MB, formingT-Hg2+-T in the DNA duplex. At this moment the
fluorescence of the MB was restored as an output, resulting in the fluorescence “on”
state (Scheme 1 B). The fluorescence intensity would be proportional to the
concentration of Hg2+. Therefore, the Hg2+ could be detected based on the fluorescence
measurement. This is the first cycle of the logic gate.
The second cycle of the logic gate can be used to detect I-. At this cycle, Icould be functional as the second input. The principle is based on the strong binding
affinity between I- and Hg2+.Their binding constant is 1029 that is much larger than that
of the T–Hg2+–T complex.16 As a result, with the addition of I-, the T–Hg2+–T complex
was disrupted by the formation of HgI2. At this moment, due to the loss of Hg2+ between
the MB and the assistant probe, the MB would reform to the original hairpin structure,
6

leading to the quenching of the fluorescence, again displaying the fluorescence “off”
state (Scheme 1 A). The extent of the fluorescence decrease would be proportional to
the concentration of I-. Therefore, by measuring the fluorescence intensity changes, the
concentration of I- could be detected. In this cycle the fluorescence decrease was an
output.

B

A

Figure 1. (A) Fluorescence intensities of the MB logic gate at 518 nm in the presence
of different inputs. (B) Truth table for the INHIBIT logic gate.
Hg2+ and I- were defined as the two inputs for our logic gate, and fluorescence
intensity change at 518 nm was defined as an output. For input, the presence of Hg2+
and I- was defined as 1, and their absence was defined as 0. For output, the original
fluorescence intensity of MB was considered as 0, and the enhanced fluorescence was
defined as 1 (Figure 1A). The four possible input combinations were (0, 0), (1, 0), (0,
1) and (1, 1), as shown in the truth table (Figure 1B). With no input, or with I- input
alone, the output was 0. With Hg2+ input alone the output signal was 1. When the two
inputs were introduced together into the system, the strong binding force between Hg2+
and I- released the Hg2+ from the T–Hg2+–T complex and the fluorescence output signal
was 0.
3.1.1. Feasibility of the DNA INHIBIT logic gate for the detection of Hg 2+ and I-.
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The feasibility of the designed fluorescent MB logic gate for the detection of
Hg2+ and I- was investigated by monitoring the fluorescence intensity changes as a
function of the reaction time. The result is shown in Figure 2. First, the fluorescence of
the logic gate increased as the injection of 200 nM Hg2+, and it plateaued at 300 s.

Figure 2. Real-time fluorescence intensities of the MB logic gate with the addition of
Hg2+ (200 nM) and I- (12.80 μM). 𝜆ex = 480 nm, 𝜆em = 518 nm.
This process demonstrated that the MB logic gate could be triggered to “on” state when
the input Hg2+ was present. At the plateaued moment, 12.80 μM I- was added to the
system for turning off the logic gate. The result demonstrated that the fluorescence
intensity decreased immediately after the addition of I-. After 120 s the fluorescence
signal returned to the original level where the Hg2+ input was not added. Clearly, the
second input of I- quickly led to the fluorescence logic gate “off”. Ultimately, this
fluorescence MB logic gate could be used for sensing both Hg2+ and I- by measuring
the fluorescence intensity changes.
3.1.2. Performance of the DNA INHIBIT logic gate.
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The performance of the logic gate was tested as shown in Figure 3. At no input
(Figure 3, curve a) and I- input alone (Figure 3, curve b), the output of fluorescence
intensity changes showed 0. When the Hg2+ input was added, the Hg2+ mediated MB
hybridization with the assistant probe and led to the open structure of MB and the
fluorescence intensity of MB increased dramatically, giving an output signal of 1
(Figure 3 curve c). Finally, the two inputs with the concentrations of 200 nM and 6.40
μM of Hg2+ and I- were introduced together into the system. As designed, the
fluorescence output signal was 0 (Figure3, curve d). The whole digital behavior could
be finished within 7 min. The INHIBIT gate process was performed in the aqueous
solution, showing convenience of the logic gate.

Figure 3. Fluorescence emission spectra of the MB logic gate to different inputs: a) I(0 μM) + Hg2+ (0 nM); b) I- (6.40 μM) + Hg2+ (0 nM); c) I- (0 μM) + Hg2+ (200 nM); d)
I- (6.40 μM) + Hg2+ (200 nM).
The operation reversibility of this logic gate was investigated by alternating
the addition of Hg2+ and I-. As shown in Figure 4, the on/off switching behavior of the
logic gate was reversible although after a cyclic treatment the fluorescence intensity
was slightly decreased at the “on” state and increased at the “off” state. The slight
decreases at the “on” state might result from the dilution because the total volume
increased by alternating addition of Hg2+ and I-. And the slight increases at the “off”
state might be due to the presence of extra Hg2+ in the complex. Overall, the results
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indicated that the operation of the logic gate was reversible, providing its application
potential.

Figure 4. Reversible fluorescence signal changes of the MB logic gate with cyclic
treatment of Hg2+ (200 nM) and I- (0.40 μM).
3.2. Optimization of the Logic Gate Conditions.
In order to obtain optimal results, some reaction conditions that would affect
the MB hybridization and fluorescence intensity were investigated.
3.2.1. Concentration of the assistant MB probe.
The function of the assistant MB probe was to hybridize MB. The
concentration of this probe would significantly affect the function of the logic gate. As
a result, the optimal concentration of the assistant probe was investigated. A 1.0 μL
aliquot of 1.0 μM MB and 0.3 μL, 100.0 μM Hg2+ were mixed in a 100.0 μL reaction
buffer. Afterwards, various concentrations of assistant probe from 100 nM to 350 nM
were added into the solution. The fluorescence intensity of the solutions with and
without Hg2+ was detected under different assistant probe concentrations.
As shown in Figure 5A, at a high concentration of the assistant probe, the MB
was easily opened without Hg2+, resulting in a high background signal (column 1).
However, at a low concentration of the assistant probe, it was difficult to open the MB
even in the presence of Hg2+ (column 2), resulting in a decreased fluorescence signal
for the detection of Hg2+. Both situations would decrease the detection sensitivity. The
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effect of the assistant probe concentration on the fluorescence enhancement of the MB
logic gate was further calculated as shown in Figure 5 B. The optimal concentration
of the DNA assistant probe was 200 nM that gave the highest signal-to-noise ratio. In
the following experiments, a concentration of 200 nM assistant probe was chosen as
the optimal concentration.

Figure 5. (A) Fluorescence intensity of the logic gate at different concentrations of
assistant probe. 1: without Hg2+; 2: 300 nM Hg2+. (B) The fluorescence intensity ratio
of the logic gate with 300 nM Hg2+ to that without 300 nM Hg2+ changed with the
concentration of the assistant probe. MB: 10 nM; temperature: 32℃; 𝜆ex= 480 nm, 𝜆em=
518 nm. (C) Fluorescence intensity of the sensor at different temperatures. F:
fluorescence intensity of the sensor in the presence of the 300 nM Hg2+; F0: fluorescence
intensity of the sensor in the absence of the Hg2+. MB: 10 nM; assistant probe: 200 nM.
𝜆ex = 480 nm, 𝜆em = 518 nm.
3.2.2. Temperature effect.
Temperature of the reaction solution affected the hybridization of the MB with
the assistant probe, and further impacted the fluorescence intensity of the MB logic gate.
Over a certain range, the higher the temperature, the easier the double-stranded DNA
dehybridization. Therefore, the effect of temperature on the fluorescence enhancement
of the logic gate was investigated. Based on the DNA hybridization reaction
temperature range, we choose 22 – 36℃ for investigation of the temperature effect on
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the signal-to-noise ratio. For different temperatures, the fluorescence intensity of the
system with and without Hg2+ was measured as shown in Figure 5B. The signal-tonoise ratio increased with the increase of temperature in the range of 22 - 32℃, and
then decreased after 32℃. Therefore, 32 ℃ was chosen as the optimal temperature for
the assay.
3.3. Hg2+ Detection.
3.3.1. Sensitivity study.
To test the sensitivity of the designed

MB based logic gate for the Hg2+

detection, the MB logic gate system was mixed with various concentrations of Hg2+ and
the fluorescence intensities of the system were detected under the optimal conditions.
As shown in Figure 6A, upon increasing the Hg2+ concentration, the peak value of the
fluorescence spectra increased, indicating a more efficient hybridization process
between the assistant probe and MB and leading to the opening of MB and the
restoration of the fluorescence intensity. The fluorescence enhancement of the MB logic
gate system was sensitive to Hg2+ in a concentration-dependent manner (Figure 6B).
The linear relationship between the fluorescence intensity and the Hg2+ concentration
was in the range of 10 - 200 nM (R2 = 0.9834). The limit of detection (LOD) was 7.9
nM based on 3 times of signal-to-noise ratio.

The result was lower than US EPA

defined toxicity level of Hg2+ in drinking water (10 nM).
3.3.2. Selectivity study.
To validate the selectivity of this assay for Hg2+ detection, competing metal
ions, including Ni2+, Zn2+, Cu2+, Mn2+, Co2+, and Fe2+, were tested under the same
condition

with a concentration of 5 times higher than that of Hg2+. As shown in

Figure 7, the fluorescence intensity of the MB logic gate system showed little changes
in the presence of the majority of the interference metal ions. The Mn2+ gave a higher
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signal than other ions. However, it was only 14.2 % of the fluorescence intensity of
Hg2+ ions. The results showed the excellent selectivity for the Hg2+ detection over other
metal ions.

Figure 6. (A) Fluorescence response of the MB logic gate to Hg2+. The fluorescence
emission spectra are shown for different Hg2+ concentrations from 0, 10, 50, 100, 200,
500 to 1000 nM. (B) Changes of the fluorescence intensity at 518 nm of the MB based
logic gate with different concentrations of Hg2+. The inset is the calibration curve of the
MB based logic gate to the detection of Hg2+.

Figure 7. Interference test of different metal ions for the logica gate. Concentration of
Hg2+: 200 nM; concentration of other metal ions: 1000 nM.
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3.4. Iodide Ion Detection.
3.4.1. Sensitivity study.
As discussed previously, I- as a second input will turn off the logic gate. The
change of the fluorescence intensity will be related to the amount of I-. To investigate
the sensitivity for I- detection, different concentrations of I- were added into the 200 nM
Hg2+, 10 nM MB system to monitoring the fluorescence intensity. As shown in Figure
8A, with the increase of I- concentration, a gradual decrease of the fluorescence was
observed. This demonstrated the competition between I- and thymine for Hg2+. Figure
8B showed that the fluorescence decrease was dependent on the concentration of I-.
Linear relationship (R2 = 0.9983) between the fluorescence decrease and the Iconcentration was obtained when the concentration of I- varied from 0 to 0.40 μM (inset
of Figure 8B). The LOD for I- was calculated to be 42 nM that was lower than the
reported colorimetric method of 6 μM37 and the graphene oxide based fluorescence
method of 100 nM.16 In addition, the process for the detection of I- using Hg2+/MB
system was faster than the reported methods. Compared to the graphene oxide based
fluorescence method for the iodide detection, this reaction time was 6 times shorter
(Figure 2).16
3.3.2. Selectivity study.
The selectivity of this assay for the detection of I- was investigated by testing
some common competing anions, including Cl-, Br-, F-, SO42-, ClO3-, HCO3-, HPO4- ,
NO3- and IO3-, at a concentration of 6.40 μM under the same condition. The results
showed that only I- decreased the fluorescence intensity dramatically (Figure 9),
showing a 71.7% decrease of the original value. While, other anions showed
insignificantly changes on the fluorescence signals of the Hg2+/MB system. Among
them, the largest decrease was from Br-, showing an 8.6% decrease on the fluorescence
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intensity. This was 8.3 times lower than that with I-. The student t test (p < 0.01) showed
that there was significant difference between the addition of I- and Br-. Overall, the
sensitivity and selectivity investigation for the I- detection demonstrated that this
Hg2+/MB system was suitable for the detection of I- against other competing anions.

Figure 8. (A) Fluorescence response of the MB logic gate to I- ions. The fluorescence
emission spectra are shown for different I- concentrations from 0, 0.05, 0.10, 0.20, 0.40,
0.80, 1.60, 3.20, 6.40 to 12.80 μM. (B) Changes of the fluorescence intensity at 518 nm
of the MB based logic gate with different concentrations of I-. The inset is the
calibration curve of the MB based logic gate for the detection of I-.

Figure 9. Interference study of different anions to the MB-based logic gate. The
concentration of all the ions: 6.40 μM.
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3.5. Real Sample Detection.
Table 1. Detection of Hg2+ and I- in tap water samples (n=3).
Target

Added

Found

Recovery

Hg2+

100 nM

108 ±15 nM

108%

150 nM

145 ±16 nM

97%

0.10 µM

0.10 ±0.03 µM

100%

0.30 µM

0.31 ±0.06 µM

103%

I-

To demonstrate the real application of the developed sensing system, we
detected tap water using the logic gate. Different amounts of Hg2+ and I- were spiked
into the tap water samples. All samples were first filtered with a 0.2 µm membrane.
Afterwards, the concentration of Hg2+ and I- in the samples were analyzed. The results
are shown in Table 1. The recoveries ranged from 97% to 108%. This result indicated
that the present logic gate would be applicable for the detection of Hg2+ and I-.

4.

Conclusions

In conclusion, a simple, rapid and sensitive logic gate based on a MB was
developed for sensing Hg2+ and I-. The fluorescence of MB logic gate increased with
the assistant of Hg2+ in a concentration-dependent manner. With this assay, the LOD of
Hg2+ was achieved as low as 7.9 nM. Furthermore, the fluorescence intensity of the
Hg2+/MB system decreased with the addition of I- because of a stronger binding force
between the Hg2+ and I-. The LOD of I- was calculated to be 42 nM which was lower
than other reports. Based on the fluorescence change of the MB logic gate system with
the addition of Hg2+ or/and I-, a DNA INHIBIT logic gate was constructed. To the best
of our knowledge, this was the first molecular MB based logic gate to detect Hg2+ and
16

I-, which expanded the applications of the MB in the fabrication of the chemical
Boolean logic gates.
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CHAPTER II
ULTRASENSITIVE DETECTION OF 3´-5´EXONUCLEASE ENZYMATIC
ACTIVITY USING MOLECULAR BEACONS
1. Introduction
DNA exonucleases are enzymes that digest DNA sequences from 3´termini or 5´-termini. Within the exonuclease family, the enzymatic activity of
3'- 5' exonuclease plays a key role for several important cellular and
physiological processes, such as promoting genetic recombination reactions, 38
keeping fidelity of DNA replication39 and repairing DNA double-strand breaks.40
Both overexpression and lack of 3'- 5' exonuclease enzymatic activity will cause
serious diseases and lead to more susceptible to cancers and other diseases under
stress conditions.41, 42 For example, a major 3'- 5' exonuclease named TREX1
could inhibit the innate immune response to HIV.43, 44 Therefore, the detection of
the 3'- 5' exonuclease activity could be used for the diagnoses and therapies for
several diseases.
Traditional approaches for the detection of 3’-5’ exonuclease activity
are based on radioisotope labeled DNA,45 which are cost-prohibitive, timeconsuming, and could cause safety concerns.46 Therefore, it is urgent and useful
to develop an efficient, sensitive and easily-operated method for evaluating the
3'- 5' exonuclease activity. Recently, fluorescence-based methods have been
developed for the detection of different enzymes,
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such as polymerases, ligases, and endocleases.47-50 However, only a few studies
were published for the detection of 3'- 5' exonuclease activity with the
fluorescence-based assay.51, 52 For example, Leung et al. developed a label free
fluorescence assay for the detection of 3'- 5' exonuclease activity based on the Gquadruplex-binding probe.53 This assay showed great advantages over the
traditional methods. However, its limit of detection was 5 U/mL only. Recently,
Su et al. used the single-labelled DNA probe to detect the activity of Exo III with
the limit of detection of 0.04 U/mL. However, a phosphorothioated base in the
3’ terminal should be modified in order to achieve the selectivity to the Exo III,
which increased the cost and complexity of the detection system.54 To overcome
these limitations of these methods, we developed a fast, sensitive and costeffective method to detect the activity of 3'- 5' exonuclease based on the
traditional molecular beacon (MB).
A MB is a single-stranded DNA sequence that can form a hairpin
structure modified with a fluorophore and a quencher on the 5' - and 3'-ends,
respectively. MBs have been developed rapidly for biosensor applications in the
last few decades.55, 56 Because of the low background fluorescence signal and
excellent selectivity of MBs, a high signal-to-background ratio can be achieved
using MBs for detection of DNA, mRNA, proteins, metal ions, and small
molecules.10,

27, 57-61

Moreover, MBs have been used for the detection of

enzymatic activities, such as the activity of the endonuclease, 47 polymerase,48
ligase49 and other enzymes which can change the nucleic acid conformation. 62
However, so far, the traditional MBs have not been applied for the detection of
exonuclease activities. Therefore, an ultrasensitive and ultra-rapid fluorescence
assay for the detection of 3'- 5' exonuclease activity based on MBs was developed
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in this work. Exo III was used as a model that contains the activities of 3'- 5'
exonucleases to illustrate the proof-of-concept of our method. Surely, Exo III
does not exist in human body. However, other enzymes containing the 3'- 5'
exonucleases activities in human are expected to be detected by this method
because they contain the same enzymatic activity. The dual-MB system
developed in this work can detect the 3'- 5' exonucleases activities with limit of
detection of 0.01 U/mL in buffer and 0.04 U/mL in 10 times serum sample. This
implied that the dual-MB system has the potential for evaluating the 3'- 5'
exonucleases activities in order to investigate the disease generating process,
diagnosis and therapy strategies.
2. Experimental Section
2.1. Chemicals and Materials
DNA sequences used in this work were purchased form Fisher Scientific. The
sequences

for

molecular

beacons

(MBs)

were:

5'-

FAMCCACCAGTTTTTTAGCTGAGGGTGG-BHQ1-3' (FAM-MB) and 5'-Cy5CCTCGAGTTTTTTAGCTGATCGAGGTTGTG-BHQ2-3' (Cy5-MB), respectively.
All the exonuclease enzymes (Exo III, Exo I, T7 Exo, T5 Exo, Exo T and RecJf) and
10X NEBuffer 4 (20 mM Tris-acetate, 50 mM potassium acetate, 10 mM Magnesium
Acetate and 1 mM Dithiothreitol pH 7.9 @ 25 °C) were purchased from New England
Biolabs, Inc. The deionized water (18.3 MΩ •cm) was produced from the Millipore
water purification system.
2.2. Apparatus
Fluorescence experiments were all performed using a Fluorolog-3
Spectrofluorometer with a 450 W xenon lamp (Jonin Yvon-Spex, Instruments S.A.,
Edison, NJ). For the FAM fluorescence detection, the excitation wavelength was 480
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nm with an emission range of 500-600 nm. The fluorescence intensity at 518 nm was
used to evaluate the performance of the proposed assay. For the detection of Cy5, the
excitation was 645 nm with an emission range of 655-750 nm. The fluorescence
intensity at 660 nm was used to evaluate the performance of the proposed assay. Both
the excitation and emission slit widths were set to 5.0 nm. All the experiments were
carried out at 37 °C for 200 s.
2.3. Exo III Detection Based on FAM-MB
A 10 nM FAM-MB sample was incubated in 50 µL 1X NEBuffer 4 at 37 °C.
A 0.20 U Exo III aliquot was then added into the solution to incubate for 200s. Finally,
the fluorescence of the solution was detected. In contrast, no Exo III was added to the
control solution and the fluorescence intensity was monitored for 200 s.
To investigate the sensitivity of the assay for Exo III, FAM-MB (10 nM) was
mixed with different concentrations of Exo III varying from 0.04 U/mL to 4.00 U/mL.
The fluorescence intensity of FAM at 518 nm was recorded after 200s. The calibration
curve was obtained by plotting the relative fluorescence intensity vs the concentrations
of the Exo III. The selectivity of the assay for the detection of Exo III was investigated
by incubating FAM-MB (10 nM) with different exonucleases including T7 Exo, Exo I
and RecJf at the concentration of 4.00 U/mL. The fluorescence intensity was also
measured at 200 s for each exonulease.
The effects of pH on the enzymatic activity of Exo III were investigated by
incubating 10 nM FAM-MB in 50 µL 1X NEBuffer 4 at 37 °C, with the addition of
0.20 U Exo for 200 s. The pH varied from 5.5 to 9.5. For the investigation of effect of
divalent ions, 10 nM FAM-MB was incubated in 50 µL 1X NEBuffer 4 at 37 °C with
addition of 0.3 mM Cu2+, Ca2+ and Mn2+, respectively. Then, 0.20 U Exo III was added
into each solution to incubate for 200 s.
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2.4. Distinguishing Exonucleases Based on Dual-MB System
FAM-MB (10 nM) and Cy5-MB (10 nM) were incubated in 50 µL 1X
NEBuffer 4 at 37 °C. 0.20 U Exo III, T5 Exo and RecJf were then added to the solution
to incubate for 200 s. Finally, the fluorescence of FAM and Cy5 were detected.
Properties and expected responses of the exonucleases in dual-MB system are
summarized in Table 1.
3. Results and Discussion
3.1. Detection of Exo III with MB
As shown in Figure. 10A, a 6-carboxyfluorescein (FAM) modified MB (FAMMB) with blunt 3'-termini was used as the probe. Because of the hairpin structure of the
MB, FAM was close to the quencher (Black Hole Quencher-1, BHQ1) modified on the
3'-termini. The fluorescence of the FAM was quenched by BHQ1 through effective
Förster resonance energy transfer (FRET). However, in the presence of Exo III, whose
substrate is blunt or recessed 3'-termini, the FAM-MB would be digested by Exo III
from the 3'-termini. Because the quencher was modified on the last mononucleotide of
the 3'-termini, with the removal of the last mononucleotide, the quencher was also
removed from the MB by Exo III. As a result, the fluorescence of the FAM was restored.
As shown in Figure. 1B, the fluorescence intensity of FAM-MB solution increased by
about 18 times after the reaction with 4.00 U/mL Exo III for 200 seconds (Figure. 10B,
curve a) compared to the control that has no Exo III (Figure. 10B, curve c),
demonstrating that the designed FAM-MB could be an ultrasensitive fluorescence
probe to detect 3'- 5’ exonuclease activity of Exo III. In order to further confirm that
the fluorescence increase is due to the addition of active Exo III, a heat-inactivated Exo
III was used as the second control. The Exo III was heated at 80 °C for 30 min to be
inactivated before incubation with the FAM-MB. The result showed that the
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fluorescence intensity of FAM-MB was significantly diminished (Figure. 10B, curve
b).
In the investigation of sensitivity of the assay, a 10 nM FAM-MB solution was
incubated with various concentrations of Exo III (0-8.00 U/mL) at 37 °C in 50 µL 1X
NEBuffer 4. The FAM’s fluorescence intensity increased as the concentration of Exo
III increased (Figure. 11A). The signal-to-background ratio reached 27 when the
concentration of Exo III was 8.00 U/mL. The total detection time is less than 200 s
because the fluorescence intensity reached a plateau at 200 s after the addition of Exo
III. In the following experiments, the incubation time of 200 s was chosen.

Figure 10. (A) The working principle of the detection of Exo III enzymatic activity
based on FAM-MB. (B) Fluorescence emission spectra of 10 nM FAM-MB in 50 μL
1X NEBuffer 4. (a) 4.00 U/mL Exo III; (b) 4.00 U/mL heat-inactivated Exo III; (c) no
Exo III. λex= 480 nm.
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Figure 11. The detection of Exo III based on FAM-MB. (A) Time-dependent
fluorescence responses in the presence of different concentrations of Exo III. From
bottom to top: 0, 0.04, 0.10, 0.20, 0.40, 1.00, 2.00, 4.00, 8.00 U/mL of Exo III in 1×
NEBuffer 4. (B) The plot of the fluorescence enhancement of different concentrations
of Exo III. Reactions were performed in 50 µL of 1× NEBuffer 4 with 10 nM FAMMB at 37 °C for 200 s. Inset: the two calibration curves in different concentration ranges.
(C) Selectivity of the assay for Exo III over other exonucleases. Fluorescence
enhancement of the FAM-MB system responded to 4.00 U/mL exonucleases.
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The fluorescence enhancement of the FAM-MB system was proportional to
the concentration of Exo III. The dynamic range was from 0.04 U/mL to 8.00 U/mL.
There were two linear ranges for the calibration curve. The first one was in the low
concentration range (0.04 U/mL-0.40 U/mL); the calibration curve in the first linear
range is showed in the top inset of Figure 11B. The regression equation was Y =
18.029X +1.6564 with a correlation coefficient of 0.9766. The second linear range was
from 0.40 U/mL to 8.00 U/mL whose calibration curve was showed in the bottom inset
of Figure. 11B. The regression equation was Y = 2.5011X +7.5561 with a correlation
coefficient of 0.9989. Y and X represented the relative fluorescence and the
concentration of Exo III in the unit of U/mL, respectively. The limit of detection (LOD)
was 0.01 U/mL based on three times of the signal-to-noise level. This was 500 times
lower than that of the G-quadruplex-binding label-free fluorescence method.16
Next, we investigated whether this FAM-MB assay could selectively detect
Exo III from other types of exonucleases. According to the property of Exo III, any
exonucleases containing a duplex DNA substrate may interfere with the detection of
Exo III. T7 exonuclease is such an exonuclease, which acts on duplex DNA in the 5'3' direction. In addition, Exo I and RecJf belong to the similar exonuclease family with
Exo III. Exo I can catalyze the removal of nucleotides from single-stranded DNA in the
3'- 5' direction, and RecJf can catalyze the removal of deoxynucleotide monophosphates
from single-stranded DNA in the 5'- 3' direction. Therefore, these three exonucleases
were chosen to investigate the assay selectivity. Encouragingly, the T7 exonuclease did
not induce dramatic fluorescence enhancement with the same concentration of the Exo
III (Figure. 11C). This result may have benefited from the rapid detection of the
fluorescence within 200 s of reaction time. Similarly, the fluorescence enhancement
from Exo I and RedJf were limited as well (Figure. 11C).
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3.2. The Stability and Effect of Ions
The stability of the probe was also investigated. Generally, the pH not only would
affect the hybridization of the MB, but could also affect the activity of the exonuclease.
Thus, the pH value should play a crucial role in the stability of the MB probe. We chose
five buffer solutions with different pH values in the range of 5.5 to 9.5 to test the
fluorescence intensity of the MB probe. The results are shown in Figure. 12A. The
highest signal-to-background ratio was gained when the pH was 7.5. Both the acid and
alkali conditions led to the decrease of the signal-to-background ratio. Apparently, the
pH value significantly affects the stability of the MB probe.

Figure 12. The stability investigation of the MB system for the detection of Exo III. (A)
The effect of pH on the reaction rate of the MB system to Exo III. (B) The effect of
divalent ions on the Exo III activity of the MB system to Exo III.
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Furthermore, we investigated the effects of metal ions on the activity of
exonucleases. It was reported that some divalent ions would inhibit the activity of the
exonucleases to cleave DNA phosphodiester bonds.63 Thus, the effects of three common
divalent ions, including Cu2+, Ca2+ and Mn2+, on the activity of the Exo III were
investigated. These cations might be present in complex samples including serum or
cells. As shown in Figure. 12B, the addition of any of these ions would dramatically
affect the activity of Exo III compared to the control. Under the same concentration,
the Cu2+ reduced the MB probe signal over 95 %. Therefore, the designed MB probe
has fairly good selectivity to the Exo III over both other types of exonucleases and metal
ions.

Figure 13. The fluorescence intensity responded to 10 nM FAM-MB (a), added with
4.00 U/mL T5 exoclease (b) or 4.00 U/mL Exo III (c).
3.3. Design of Dual-MB System
However, even though the T7 exonuclease did not affect the detection of
Exo III, other similar exonucleases may give a false signal if they could react fast with
the MBs. We found that the T5 exonuclease, an exonucleas that has 5'- 3' exonuclease
activity, degraded DNA in the 5'- 3' direction in both single-stranded and doublestranded DNAs. When the T5 exonuclease was incubated with the FAM-MB system
for 200 s, the fluorescence of the FAM increased as the addition of Exo III (Figure 13).
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In order to overcome this interference, a dual-MB system was developed, containing
not only FAM-MB, but also a Cy5-MB with a 3´extention terminus.
As shown in Figure 14A, in the dual-MB system, the Exo III could only catalyze
the digestion of the duplex DNA with blunt or recession 3'-termini to induce the
fluorescence enhancement of the FAM, but not the Cy5. In contrast, the T5 exonuclease
could catalyze both single-stranded DNA and double-stranded DNA from 5'-termini;
as a result, it would induce the fluorescence enhancement of both FAM and Cy5. RecJf
exonuclease, which can only catalyze the removal of deoxynucleotide monophosphates
from a single-stranded DNA in the 5'- 3' direction, would not induce any fluorescence
enhancement. The properties of the three exonucleases and anticipating fluorescence
responses were summarized in the Table 2.

Figure 14. (A) Schematic illustration of the dual-MB system for distinguishing different
exonucleases. (B) Fluorescence enhancement patterns of the dual-MB system with 4.00
U/mL Exo III, T5 exonuclease and RecJf. The dual-MBs system 20 contained 10 nM
FAM-MB and 10 nM Cy5-MB in 50 GL of 1×NEBuffer 4, incubated at 37 °C for 200
s to detect the fluorescence intensity. λex (FAM)=480 nm, λem (FAM)= 518 nm. λex
(Cy5)= 645 nm, λem (Cy5)= 660 nm.
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Table 2. The properties of different exonucleases. “+” indicates fluorescence
enhancement; “-” indicates constant fluorescence.
Exonuclease

Substrate

Direction

FAM-MB

Cy5-MB

Exo III

dsDNA

3'- 5'

+

-

T5 Exo

dsDNA,ssDNA

5'- 3'

+

-

RecJf

ssDNA

5'- 3'

-

-

Using this dual-MB system, three exonucleases at the concentration of 4.00
U/mL were detected (Figure 14B). As the negative control, the RecJf exonuclease
showed no fluorescence enhancement of FAM and Cy5, which meant that both FAMMB and Cy5-MB were not digested by the RecJf exonuclease. When Exo III was added
into the solution, the fluorescence of FAM increased by 16.6 times, while the
fluorescence of the Cy5 did not change because this 3' extention Cy5-MB was not the
substrate of Exo III. However, when T5 exonuclease was added into the solution, the
fluorescence intensity of FAM increased by 12.8 times and the fluorescence intensity
of Cy5 increased by 6.3 times. If the fluorescence enhancement for each dye was
defined as 1, and no fluorescence enhancement defined as 0, the responses of the dualMB system in the manner of (FAM, Cy5) for Exo III, T5 exonuclese, and RecJf were
(1, 0), (1, 1) and (0, 0), respectively. From these different response patterns, Exo III, T5
exonuclease, and RecJf could be distinguished from each other.
3.4. Complex Samples Investigation

29

Figure 15. The fluorescence enhancements of FAM-MB in different solutions. The
concentrations of Exo III were 4.00 U/mL.
To test the feasibility of the designed MB probe for the detection of Exo
III we applied the probe to complex samples, including cell culture medium and
fetal bovine serum. As shown in Figure 15, with the same concentration of Exo
III, the fluorescence enhancements of FAM in the 10 times diluted RPMI 1640
medium and fetal bovine serum were lower than that of the ideal buffer solution.
The lower fluorescence enhancements of FAM in the complex samples compared
with the ideal buffer might be due to the high background signal of these two
matrixes when they were excited at 488 nm irradiation. In order to show how
much the other exonucleases would interfere the detection of Exo III, T5
exonuclease and RecJf were added into the dual-MB systemin the complex
sample. As shown in Figure 16A, T5 exonuclease induced the fluorescence
enhancement of both FAM and Cy5 in the serum sample. In contrast, RecJf
exonuclease did not cause any fluorescence enhancement for these two dyes. The
fluorescence intensity of FAM increased with the addition of Exo III. In contrast,
the fluorescence intensity of Cy5 kept constant (Figure 16A), which was
consistent with the results in the buffer solution. Therefore, this dual-MB system
could eliminate the interference of other exonuclease for the detection of the 3'30

5' exonuclease enzymatic activity in complex sample by the different
fluorescence enhancement combinations.
Because the fluorescence enhancements in these two complex samples were
not consistent with that in the ideal buffer, a new calibration curve had to be prepared
for the detection of the Exo III in the complex samples. The fetal bovine serum was
chosen as the example of the complex sample for the preparation of the calibration
curve. As shown in Figure. 16B, the complex time fluorescence enhancements of FAM
in the dual-MB system with addition of different concentrations of Exo III were
monitored in 10 times diluted fetal bovine serum. Figure. 16C demonstrated the
calibration curve of the dual-MB system for the detection of Exo III in the 10 times
diluted fetal bovine serum. A similar curve at the concentration from 0 to 8.00 U/mL
was exhibited as that in the ideal buffer except the corresponding relative fluorescence
intensity was lower than those in the ideal buffer. Two linear ranges from 0 to 0.40
U/mL and 0.40 to 8.00 U/mL were observed in the complex sample, respectively. In
order to further investigate the feasibility of this method for the detection of
Exonuclease III activity in complex biological sample, fresh mice serum was used as
another complex sample. As shown in Figure 17, the detection range was from 0 to 8
U/mL with similar two different linear ranges, including 0 to 0.4 and 0.4 to 8 U/mL.
The limit of detection in this sample was 0.03 U/mL according based on three times of
the signal-to-noise level. This is 3 times higher than that in ideal buffer, which might
be caused by the complexity of the mice serum. However, all the results indicated that
this dual-MB system might be used in complicated samples for the real-time detection
of the enzymatic activity of Exo III.
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As shown in Figure 11B and Figure 16C, the Exo III calibration curves in buffer
and 10 times-diluted fetal bovine serum demonstrated an initially high slope up to Exo
III concentration of 0.4 U/mL followed by a decrease in slope. This might be due to the
fixed substrate’s concentration. Theoretically, the calibration curve should

Figure 16. (A) The fluorescence enhancements of FAM-MB and Cy5-MB in 10 times
diluted fetal bovine serum with the addition of 4 U/mL Exo III, T5 Exo and RecJf Exo.
(B) Time-dependent fluorescence responses in the presence of different concentrations
of Exo III. From bottom to top: 0, 0.04, 0.20, 0.40, 2.00, 4.00, 8.00 U/mL of Exo III in
10 times diluted fetal bovine serum. (C) The plot of the fluorescence enhancement of
different concentrations of Exo III. Reactions were performed in 50 µL of 10 times
diluted fetal bovine serum with 10 nM FAM-MB and 10 nm Cy5-MB at 37 °C for 200
s. Inset: the two calibration curves in different concentration ranges.
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Figure 17. (A) Time-dependent fluorescence responses in the presence of different
concentrations of Exo III. From bottom to top: 0, 0.08, 0.20, 0.40, 0.80, 2.00, 4.00, 8.00
U/mL of Exo III in 10 times diluted fresh mice serum. (C) The plot of the fluorescence
enhancement of different concentrations of Exo III. Reactions were performed in 50 µL
of 10 times diluted fresh mice serum with 10 nM FAM-MB and 10 nm Cy5-MB at
37 °C for 200 s. Inset: the two calibration curves in different concentration ranges.
be off from the linear range when the concentration is higher than the saturated
concentration. The reason for the second linear range might be from the excess residue
intact the MB, which could be slowly digested by higher concentration of Exo III
beyond the theoretical linear concentration limit. In this case, Exo III with a
concentration of 0.40 U/mL was enough to digest most of the FAM-MB in the system.
This triggered a larger slope of the calibration curve in the low concentration range.
However, when the concentration of Exo III was higher than the turning point of 0.40
U/mL, even most of the FAM-MB was digested by the Exo III, the excess Exo III would
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no longer have enough substrate to digest. As a result, the slope of the calibration cure
in the higher concentration range decreased.
4. Conclusions
In conclusion, an ultrasensitive, rapid and simple fluorescence method has
been developed for the detection of Exo III. The dynamic range of the assay was 0.04
U/mL to 8.00 U/mL with the detection limit of 0.01 U/mL. The total incubation time
for the assay was 200 s which was about 10 times faster than the label-free fluorescence
method. The assay showed good selectivity over T7 exonuclease, Exo I and RecJf
exonuclease. Even the T5 exonuclease would interfere the detection of Exo III, the dualMB system was successful for eliminating the interference of other exonucleases.
Finally, the designed dual-MB probe was applied to the monitoring of the enzymatic
activity of Exo III in complex samples. The results suggested a great potential of the
dual-MB probe for the detection of Exo III levels in complex samples. The proposed
fluorescence assay is expected to be used for disease diagnosis and therapy related to
the overexpression or loss of 3´-5´exonucleases and to expand the application of MBs
in the enzymatic analysis.
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CHAPTER III
LABEL-FREE FLUORESCENCE ASSAY COUPLED EXONUCLEASE
REACTION AND SYBR GREEN I FOR THE DETECTION OF T4
POLYNUCLEOTIDE KINASE ACTIVITY
1. Introduction
Phosphorylation, a transferring of γ -phosphate residues of adenosine
triphosphate (ATP) to 5´-hydroxyl terminus of polynucleotides, plays an important role
in DNA replication, DNA repair and recombination64,

65

. In these normal cellular

processes, several factors, such as chemical substances, ionizing radiation66 and
nucleases67, would cause nucleic acid lesions that contain 5’-hydroxyl termini. This 5’hydroxyl termini may lead to failure of 5’-phosphate terminal dependent repair
processes for nucleic acids, resulting in severe gene damage and diseases68,

69

.

Therefore, it is highly desirable to monitor the polynucleotide kinase activity and
inhibition for further understanding phosphorylation and related biological processes.
Normally, methods used to study the phosphorylation of nucleic acids
included radical isotope 32P-labeling, polyacrylamide gel electrophoresis (PAGE) and
autoradiography69-71. However, these methods have safety concerns (radio labelling),
and are time-consuming and complex. Recently, several electrochemical and
fluorescence sensors for monitoring kinase activities were developed72-76. The
replacement of radio labelling using fluorescence labelling in these assays eliminated
safety concerns; however, labelling fluorophores to nucleic acids increased the cost of
the assay. For example, Tang et al. reported a fluorescence
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assay for monitoring phosphorylation process using a dual-label molecular beacon77,
and Song et al. developed a real-time method for the kinase activity detection using a
singly labelled molecular beacon75. By using graphene oxide as a quencher platform,
Lin et al. developed a novel method for the kinase activity and inhibition monitoring
with a FAM modified dsDNA76. These methods provided high sensitivity for detections
in spite of labelling requirements. The development of labelling-free methods for the
detection of phosphorylation kinase activities and inhibition is still a challenge.
Integrated DNA dyes, such as SYBR Green I (SG), are very powerful tools
for fabricating DNA sensors based on their different affinities to the ssDNA and
dsDNA78, 79. They have been wildly used for the detection of DNAs80, metal ions81-83,
proteins and small molecules84 with high sensitivity and low cost. Therefore, SG could
provide a low-cost alternative for label-free detection of phosphorylation kinase
activities and inhibition. λ exonuclease (λ exo) is an enzyme that catalyzes efficiently
cleavage of dsDNA from 5’-phosphate termini to generate ssDNA and
mononucleotides. However, the cleavage efficiency of the λ exo is greatly reduced if
the 5’-termini of dsDNA is hydroxyl. In this work, we developed a simple, label-free
sensitive method for kinase activity and inhibition analysis based on the coupled λ exo
cleavage reaction and the SYBR Green I. The label-free method developed in this work
can detect phosphorylation kinase activities in the linear range of 0.25 to 1.00 U/mL
with a limit of detection of 0.11 U/mL.
2. Experimental
2.1. Materials and Apparatus
DNA sequences were purchased from Eurofins MWG Operon (Alabama,
USA). The sequences for hair-pin probe were: 5’-TGC CTA CGA CCA ATT CCA
CCT CAG CTA CCA GCA ACA GT-3’ and 5’- ACT GTT GCT GGT AGC T-3’. The
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exonuclease enzymes (T4 polynucleotide kinase and λ exo) and 10X NEBuffer 4 (50
mM potassium acetate, 20 mM Tris-acetate, 10 mM magnesium acetate and 1 mM DTT,
pH 7.9.) were purchased from New England Biolabs, Inc (NEB, U.K.). SYBR Green I
was purchased from Fisher Scientific (Pennsylvania, USA). The deionized water (18.3
MΩ•cm) was produced from the Millpore water purification system. Fluorescence
experiments were performed using a Fluorolog-3 Spectrofluorometer with a 450 W
xenon lamp (Jonin Yvon-Spex, Instruments S.A., Edison, NJ).
2.2. T4 PNK Detection and Optimization
In a typical phosphorylation and cleavage assay, 0.1 μL 10x SG, 20 nM
dsDNA probe, 0.1 mM ATP, 0.25 units of λ exo, and a series of different concentrations
of T4 PNK were added to 100 μL of 1x NEBuffer 4. After 30 min incubation at 37°C,
the fluorescence spectra were recorded with the excitation wavelength of 490 nm and
emission from 505 nm to 650 nm. The fluorescence intensity at 518 nm was used as the
detection signal. The optimal values of phosphorylation time, concentrations of λ exo
and ATP were investigated.
2.3. T4 PNK Inhibitor Evaluation
To investigate effects of the T4 PNK inhibitors on the phosphorylation
process, the reactions were performed at various concentrations of inhibitors, including
(NH4)2SO4 (0-120 mM), and Na2HPO4 (0-90 mM). All mixtures contained 0.1 μL 10x
SG, 20 nM dsDNA probe, 0.1 mM ATP, 0.25 units of λ exo, and 10 U/mL T4 PNK.
3. Results and Discussion
3.1. Scheme of the T4 PNK Activity Detection
Based on the high affinity of SG to dsDNA and the unique property of λ exo,
a label-free method was designed for the detection of T4 PNK activity. The proposed
scheme for the PNK activity detection was illustrated in Figure 18. A double-stranded
37

DNA with one duplex 5’-hydroxyl termini was used as the label-free DNA probe. An
integrating dye molecule, SG, was selected as the fluorescence signal source. The
dsDNA coupled with SG would generate strong fluorescence intensity. With the
addition of the T4 PNK, the 5’-hydroxyl termini of the dsDNA would be transferred to
5’-phosphate termini in the presence of ATP (Figure 18, step A). In the following step,
the dsDNA probe was digested by the λ exo from the duplex 5’-phosphate termini to
generate mononucletides and ssDNA (Figure 18, step B). The binding force between
the ssDNA and SG decreased dramatically, which led to a reduction of the fluorescence
intensity. The extent of the fluorescence decrease was proportional to the concentration
of T4 PNK. As a control, in the absence of T4 PNK, the λ exo digestion of the 5’hydroxyl termini dsDNA was limited due to the lack of preferred substrate. As a result,
the fluorescence intensity of the SG would have little change. With this strategy, no
fluorescence label was needed to perform the detection of T4 PNK activity.

Figure 18. Schematic diagram of monitoring the T4 PNK activity by a label-free DNA
probe coupled with SG and λ exo.
The phosphorylation process of T4 PNK could be monitored by measuring
fluorescence changes of the system using SG as the integrating dye. As shown in Figure
19, when the dsDNA probe was treated with λ exo only, it exhibited high fluorescence
intensity in the presence of SG (Figure 19 curve a). However, when the T4 PNK was
added to phosphorylate the 5’-termini of the dsDNA probe followed by the digestion
of the λ exo, much lower fluorescence intensity was observed (Figure 19, curve b). Up
to 90% fluorescence emission disappeared upon the addition of the 20 U/mL T4 PNK.
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The main reason was that the phosphorylated 5’-termini dsDNA was the preferred
substrate of λ exo. It was reported that the reaction rate of the λ exo for dsDNA with
5’-phosphoral was over 300 times faster than that with 5’-hydroxyl termini85. As a
result, the dsDNA probe phosphorylated by the T4 PNK was digested much more
rapidly than that without T4 PNK treatment by λ exo. The generated mononucleotides
and ssDNA had low affinity to the SG, resulting in low fluorescence emission signal.
The dsDNA probe without T4 PNK treatment remained the double-stranded structure
which emitted high fluorescence signal with the interaction of the SG. The following
experimental results showed that the fluorescence decrease was proportional to the
activity and concentration of the T4 PNK, which demonstrated that this label-free
system could be used for the detection of the T4 PNK activity.

Figure 19. Fluorescence spectra of the dsDNA system without T4 PNK (a) and with 20
U/mL T4 PNK (b). Reactions were performed in 100 µL of 1x NEBuffer 4 (pH = 7.9)
with 20 nM dsDNA at 37°C for 30 min. The concentrations of ATP and λ exo were 0.1
mM and 0.25 units, respectively. λex = 480 nm.
3.2. Optimization of SG Concentration
SG played a crucial role in this designed assay. Therefore, the optimal
concentration to distinguish ssDNA and dsDNA had to be investigated to obtain the
highest sensitivity of the assay. In the presence of ssDNA, a very limited fluorescence
signal was appeared (Figure 20A, curve a). However, the fluorescence intensity of SG
enhanced several times when a dsDNA was added to the solution (Figure 20 A, curve
b). The dramatic difference between curve a and curve b was the basis for distinguishing
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ssDNA and dsDNA. To obtain the optimum detection ability, the concentration of SG
must be optimized since it would affect the signal-to-background ratio of the detection.
As shown in Figure. 3B, with the increase of the concentration of SG, both the
fluorescence intensities of dsDNA and ssDNA solutions increased. To obtain the
highest difference between dsDNA and ssDNA, the fluorescence intensity of dsDNAto-ssDNA ratio was plotted against the SG concentration as shown in Figure 20C. The
highest fluorescence dsDNA-to-ssDNA ratio was reached at the concentration of 20
nM. Therefore, 20 nM SG was chosen as the optimal concentration for the following
experiments.
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Figure 20. (A) Fluorescence spectra of 40 nM SG incubated with 20 nM ssDNA (Curve
a) and dsDNA (Curve b). (B) Fluorescence intensity of dsDNA and ssDNA with the
change of the concentration of SG. (C) The fluorescence intensity ratio of dsDNA to
ssDNA with the change of the concentration of SG. Fluorescence intensity was
measured in 100 µL of 1x NEBuffer 4 (pH = 7.9) with 20 nM ssDNA or dsDNA at
37°C. λex = 480 nm.
3.3. Optimization of the Detection Parameters
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In the phosphorylation process of DNA, there are several factors that will affect the
catalysis efficiency. ATP is a co-factor for assisting in T4 PNK phosphorylation
because it provides the phosphate group to be modified on the DNA strands. The
concentration of ATP may affect the activity of the T4 PNK in the system. To gain
better analytical performance, the effect of ATP concentration on the fluorescence
intensity was studied as shown in Figure 21A. Because the fluorescence intensity of SG
will decrease when the T4 PNK was present, we used the fluorescence intensity change
as a measurement to evaluate the effect of ATP on the T4 PNK activity.
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Figure 21. (A) Optimization of ATP concentration. The concentrations of λ exo,
dsDNA, and T4 PNK were 1 unit, 20 nM, and 20 U/mL, respectively. (B) Optimization
of the reaction time. The concentrations of λ exo, dsDNA, ATP and T4 PNK were 0.25
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With the increase of the ATP concentration, the fluorescence intensity change
reached the highest point as 93% fluorescence intensity disappeared when 100 µM ATP
was introduced. As a result, 100 µM was chosen as the optimum concentration of ATP
in the phosphorylation and cleavage processes.
In this assay, λ exo was used as an enzyme to digest dsDNA after the
phosphorylation by T4 PNK. The concentration of the λ exo should be a primary factor
for affecting fluorescence intensity of the system. A higher concentration of λ exo
would increase fluorescence background signal by digesting the dsDNA that without
the phosphorylation by T4 PNK, which led to the lower signal-to-background ratio
(S/B) ratio. In contrast, the lower amount of λ exo was not enough to digest the
phospholated-dsDNA. Therefore, it is necessary to investigate the optimal
concentration of λ exo. As shown in Figure 21C, with the increase of the λ exo
concentration, the fluorescence intensity change of both solutions with T4 PNK or
without T4 PNK increased. To get the optimum (S/B), the relationship of the S/B ratio
with the amount of the λ exo was studied. It was shown that the highest S/B value was
obtained in the presence of 0.25 units of λ exo (Figure 21 D). Therefore, 0.25 units of
λ exo were used in the following experiments.
The reaction time of the T4 PNK catalysed phosphorylation and the coupled
λ exo digestion was the other crucial factor. As shown in Figure 21B, the fluorescence
intensity of SG decreased dramatically through the incubation time. The results showed
that the fluorescence intensity decreased with the increase of the incubation time to 30
min. In the first 2 min, 87.5 % fluorescence was decreased, followed by the gradual
decrease until 30 min. This is due to the rapid catalytic activity of λ exo when T4 PNK
was added to phosphorylate the dsDNA. The stable fluorescence intensity after 30 min

42

suggested the complete phosphorylation and digestion. As a result, 30 min was chosen
for the incubation time in the following experiments.
3.4. Monitoring of the Phosphorylation Process of T4 PNK
Under the optimized conditions, a series of concentrations of T4 PNK from 0
to 20 U/mL was applied to quantify the kinase activity of the T4 PNK. As shown in
Figure 22A, the fluorescence signals gradually decreased as the concentration of T4
PNK increased. The relative fluorescence intensity reached the saturation when the T4
PNK concentration reached 10 U/mL. The calibration curve between the fluorescence
intensity change and T4 PNK concentration was shown in Figure. 5B. There was a good
linear range between 0.25 to 1.00 U/mL (Figure 22B inset). The linear relationship can
be demonstrated as Y = 2.5011X + 7.5561 with a correlation coefficient of 0.9896. Y
and X represented the fluorescence intensity change and concentration of T4 PNK in
units of U/mL, respectively. The limit of detection (LOD) was 0.11 U/mL according to
the definition of 3s/slope. This result demonstrated the method as a potentially simple,
quantitative and label-free strategy for polynucleotide kinase activity assay.

Figure 22. Monitoring the T4 PNK activity. (A) Relative fluorescence intensity with
different concentrations of T4 PNK (top to bottom, 0, 0.25, 0.50, 1.00, 5.00, 10.00,
20.00 U/mL). (B) Concentration curve for T4 PNK. Inset indicated the linear
relationship between fluorescence intensity change and the concentration of T4 PNK
from 0 to 1.00 U/mL. Fluorescence intensity was measured in 100 µL of 1x NEBuffer
4 (pH = 7.9) at 37°C after 30 min incubation. The concentrations of λ exo, dsDNA, and
ATP were 0.25 units, 20 nM, and 0.1 mM, respectively. λex = 480 nm.
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3.5. Inhibition Investigation
Since phosphorylation plays important roles in several bio-processes, the
inhibition to the T4 PNK activity was also important to evaluate. Therefore, the
inhibition effects of the ammonium sulphate and sodium hydrogen phosphate on
phosphorylation were also investigated through this label-free fluorescence assay. It
was reported that these inhibitors had no effect on the activity of the λ exo76; thus, they
can be used for the evaluation of the inhibition on the T4 PNK activity. As shown in
Figure 23, the phosphorylation activity of T4 PNK was inhibited by both ammonium
sulphate and sodium hydrogen phosphate depending on the concentration of the
inhibitors. With the increase of the concentration of the inhibitors, the relative
fluorescence intensity of the system increased which indicated that the phosphorylation
process was inhibited by the high concentration inhibitors. The results showed that this
assay could investigate the various effects on phosphorylation quantitatively.

Figure 23. The effect of different concentrations of T4 PNK inhibitor. (A) Effect of
(NH4)2SO4 (0-120 mM); (B) Effect of Na2HPO4 (0-90 mM). Fluorescence intensity was
measured in 100 µL of 1x NEBuffer 4 (pH = 7.9) at 37°C after 30 min incubation. The
concentrations of λ exo, dsDNA, ATP and T4 PNK were 0.25 units, 20 nM, 0.1 mM,
and 10 U/mL respectively. λex = 480 nm.
4. Conclusions
In conclusion, we have developed a facial, quantitative, cost-effective and labelfree fluorescence assay for the detection of T4 PNK activity and inhibition coupled with
λ exo and SG. In this sensing platform, the 5’-hydroxyl group of the dsDNA was
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phosphorylated by T4 PNK in the presence of ATP, the resulting 5’-phosphoryl termini
dsDNA was digested by the λ exo in the following step. As a result, the SG integrated
in the dsDNA was released from the dsDNA which lead to the fluorescence intensity
decrease of the system. This assay offered a new opportunity in the development of
phosphorylation monitoring and related drug screening and clinical diagnostics.
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CHAPTER IV
FABRICATION OF HIGHLY FLUORESCENT GRAPHENE QUANTUM DOTS
USING L-GLUTAMIC ACID FOR IN VITRO/IN VIVO IMAGING AND SENSING
1. Introduction
Recently, graphene and its derivative graphene oxide have attracted
remarkable attention due to their extraordinary optical and electronic properties
and biocompatibility.86-89 However, applications of graphene in the fields of
bioimaging and optoelectronics are limited because graphene is a zero-bandgap
semiconductor.90 To generate a bandgap in graphenes, a zero-dimensional
derivative, graphene quantum dots (GQDs) have been developed.14, 91-95 GQDs
have strong quantum confinement and edge effect when their sizes are in the
range of 3-10 nm.96, 97 Compared to zero-bandgap graphene sheets, GQDs exhibit
stronger photoluminescence for bioimaging,98 light-emitting diodes,99 and
biosensors.92 The photoluminescence is not only attributed to the quantum
confinement effect, but also to the edge effect of the small graphene quantum
dots. Most importantly, compared to the traditional quantum dots (QDs), 17, 100-104
GQDs are chemically inert. Thus, the potential toxicity of the intrinsic heavy
metal in traditional QDs would not be a concern for GQDs. Even though the
mechanism of photoluminescence needs further investigation, a wide variety of
applications of GQDs have been developed, such as photovoltaic devices, 105
biosensing,106 drug delivery,107 cellular imaging,97 and the interaction with
biological systems.108
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A number of methods have been developed for the synthesis of GQDs.
Generally, the approaches can be divided into two groups: top-down and bottomup methods. The top-down methods are based on cutting large carbon materials,
such as carbon nanotubes, graphene sheets and carbon fibers, to form small
GQDs. For example, Pan et al. synthesized blue GQDs by a hydrothermal method
using a pre-oxidized graphene sheet.10 Zhou et al. broke C-C bonds of a graphene
oxide using the photo-Fenton reaction to produce GQDs.108 With controlling of
the photo-Fenton reaction conditions, the nanoporous graphene sheets and GQDs
were generated. Using microwave as an energy source, Li et al. synthesized
greenish-yellow luminescent GQDs by cutting a graphene oxide under acid
conditions.109 Furthermore, several other methods were developed such as acid
treatment coupled with the chemical exfoliation of carbon fibers, 93 the
electrochemical etching of a graphene electrode,110 and the ultrasonication
breaking of graphene.110, 111 Although luminescent GQDs could be obtained from
carbon sources by these top-down methods, the reaction conditions and
purification processes were complicated and time-consuming.
In contrast to the top-down approaches, bottom-up methods fabricate
GQDs from small carbon precursors

including glucose, 99 hexa-peri-

hexabenzocoronene,112 citric acid,92 etc.113 The bottom-up methods produced
GQDs with controllable morphology and well-distributed sizes. However, harsh
reaction conditions, such as using a strong acid or alkali, a long treatment period
of time, and necessary separation processes, are limitations of the bottom-up
methods. To overcome these limitations in this work, we have developed a
simple and rapid bottom-up synthetic method by carbonizing a common amino
acid, L-glutamic acid (Glu), using a heating mantle for pyrolysis. This is the first
47

report to use the L-glutamic acid for the synthesis of highly fluorescent nitrogendoped GQDs with a simple heating process. The obtained GQDs emitted various
wavelengths of fluorescence including the near-infrared fluorescence (NIR). In
the NIR region, biological samples have low background fluorescence signals,
providing high signal to noise ratio. Meanwhile, NIR radiation can penetrate into
sample matrices deeply due to low light scattering. Thus, the GQDs are
promising labeling reagents for sensitive determination and imaging of biological
targets. The fluorescence quantum yield of the developed GQDs was about 5
times higher than the GQDs from citric acids.92 We have demonstrated the
feasibility of using the GQDs in the in vitro and in vivo fluorescence imaging.
Besides the bioimaging applications, the GQDs showed a peroxidase-like
catalytic activity that was used for the sensitive detection of H 2O2.
2. Experimental Section
2.1. Materials.
L-glutamic acid, Ludox SM-30 colloidal silica (30 wt. % suspension in water),
hydrogen peroxide, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS),
fluorescein isothiocyanate (FITC) isomer I, rhodamine-101 and phosphate buffered
saline (PBS) tablet were purchased from Sigma-Aldrich. The deionized water (18.3
MΩ•cm) was produced from the Millpore water purification system.
2.2. Synthesis of GQDs.
The GQDs was synthesized by pyrolyzing L-glutamic acid. Briefly, 2.0 g Lglutamic acid was added to a glass bottle and heated to 210 °C with a heating mantle.
After the solid L-glutamic acid changed to liquid, the boiling colorless liquid turned to
brown in 45 s, which indicated the formation of GQDs. Then, 10.0 mL water was added
to the solution followed stirring for 30 min. When the solution temperature reached
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room temperature, the solution was centrifuged at 10,000 g for 30 min and the
supernatant was collected. The resultant GQD solution could be stored at the room
temperature for at least 5 months without precipitation.
2.3. Characteristics of GQDs.
A JEOL JEM-2100 high-resolution transmission electron microscope
(HRTEM) was used to characterize the GQDs at an operating voltage of 200 kV. The
size distribution of the GQDs was measured and graphed using Image J. Fourier
transform infrared (FTIR) spectra were obtained on a FT-IR spectrometer (Peking). The
Energy-dispersive X-ray spectroscope (EDS) (Oxford), which was attached on the
Hitachi SU8010 field emission scanning electron microscope (SEM) with an operating
voltage of 5 kV, was used to analyze the relative contents of carbon, nitrogen and
oxygen in L-glutamic acid and GQDs. X-ray diffraction (XRD) profiles were obtained
with Bruker AXS D8 advanced powder x-ray diffraction system using Cu Kα radiation.
Raman spectra were performed on an Aramis labRAM Raman spectrometer (Horiba
JobinYvon) using the helium-neon laser at 542 nm. A Shimadzu UV-250 UV/vis
spectrometer was used for the measurements of the UV/vis absorption of GQDs. The
fluorescence spectra, lifetime, and quantum yields were measured using a Jobin-YvonHoriba Fluorometer 3 Model (FL 3-11 spectrofluorometer). The zeta potential was
detected using the Zetasizer (Marlwen, model of Nano-ZS) by adjusting the pH of the
GQDs from 2.0 to 12.0 using PBS buffer.
2.4. Detection of Quantum Yields.
Fluorescein in 0.1 M NaOH (QY = 92 %) was chosen as a reference.114, 115 The
quantum yield was calculated according to the following equation:
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𝐴𝑆𝑇 𝐼𝑋 𝜂𝑋2
Φ𝑋 = Φ𝑆𝑇 (
)( )( 2 )
𝐴𝑋 𝐼𝑆𝑇 𝜂𝑆𝑇

Where the subscripts ST and X denote standard and sample, respectively. Φ is
the quantum yield. I represents the measured integrated fluorescence intensity. A is the
absorbance at the excitation wavelength, and η is the refractive index of the solvent.
The refractive index for the standard and sample are 1.33. The GQDs were excited at
360 nm with an emission range of 380-650 nm.
2.5. Detection of Fluorescence Lifetime.
The fluorescence lifetime of GQDs was measured using time-correlated single
photon counting (TCSPC) with the LED (370 nm) equipped on the Jobin-Yvon-Horiba
Fluorometer 3. A Ludox SM-30 colloidal silica was used as the reference. The emission
wavelength of GQDs changed from 455 to 505 and 650 nm. An emission wavelength
of 815 nm was used for the NIR fluorescence lifetime measurement.
2.6. In Vitro Fluorescence Imaging of Cells.
The fluorescence imaging of cells treated with GQDs was conducted at various
wavelengths (Zeiss LSM-510 Meta Confocal Microscope). Briefly, murine alveolar
macrophage cells (MH-S) were cultured overnight at 37 °C on plates in RPMI 1640
medium containing 10 % fetal bovine serum in a 5 % CO2 environment. Then, the
cultured cells were washed twice with PBS buffer (pH 7.4). Afterwards, a 2 mL aliquot
of 10 mg/mL GQDs in PBS was added to the cell culture medium followed by 1 hour
culture at 37 °C in a 5% CO2 environment. Finally, the MH-S cells were washed twice
using the PBS buffer and imaged using the Zeiss LSM-510 Meta confocal microscope.
2.7. In Vivo Fluorescence Imaging of Mice.
The in vivo fluorescence imaging of mice treated with GQDs was carried out
using the IVIS imaging system (IVIS Lumina XR, Caliper). The athymic BALB/c-nu
mice with weight of 20-25 g were obtained from Charles River (Wilmington, MA), and
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maintained in the University of North Dakota animal center. All animal operations were
in accord with the institutional animal use and care regulations, according to protocol
No. 1204-4 and 1204-5. The feasibility of the GQDs for in vivo fluorescence imaging
was investigated by subcutaneous and intramuscular injection. The mice were
anesthetized and injected with 100 µL of 25 mg/mL GQD PBS solution (pH 7.4)
subcutaneously on the back, and 100 µL of 25 mg/mL GQD intramuscularly in the right
back leg. The fluorescence images of the mice were taken immediately with different
excitation and emission filter combinations.
2.8. Detection of H2O2 Based on the GQD’s Catalytic Activities.
5.4 mg/mL GQDs was dissolved in 110 µL of 10 mM Tris-HCl buffer (pH =
5.0), followed by the addition of 7.2 mM ABTS. The control samples were prepared
using the same condition except for no GQDs or H2O2, respectively. The absorption
spectra of these three samples were recorded after 2 min of the reaction. Then, the
reaction conditions, such as pH, temperature, concentrations of ABTS, and
concentrations of GQDs, were optimized. Different concentrations of H2O2 were added
into the solution for the investigation of sensitivity. The absorbance at 416 nm against
the reaction time of 120 s was measured.
3. Results and discussion
3.1. Design of the Highly Fluorescent GQDs.
The objective of this work was to develop a simple bottom-up method
for the synthesis of highly fluorescent GQDs. The key factor of our design was
the usage of a green and natural L-glutamic acid as the precursor. Traditionally
the “bottom up” methods for the preparation of GQDs used some special organic
precursors, such as 3-iodo-4-bromoaniline,113 resulting in a complicated
synthetic process. However, in the synthesis of carbon nanodots, some common
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organic molecules, including citric acid,116 histidine117 and glucose,118 were used
as the precursors with the assistance of microwave. These studies revealed a
possibility of using common organic molecules to generate GQDs. Most
recently, using a citric acid as the precursor, Chen et al. successfully developed
fluorescent GQDs and graphene oxide.92 Inspired by this pioneer work, we
considered using a natural amino acid as a precursor to synthesize N-doped
GQDs based on the pyrolysis of the precursor. Our criteria for the selection of
the precursor were non-toxic, common/natural materials, containing nitrogen
groups for easy surface modification of the GQDs during their applications, and
no further capping process is needed. Considering of these criteria, we selected
L-glutamic acid. Our result demonstrated that the L-glutamic acid was an
excellent precursor for making the GQDs. The formation of a GQD from the Lglutamic acid was illustrated in Scheme 2. The solid L-glutamic acid was first
directly heated to 210 °C using a heating mantle. This temperature is the boiling
point of the L-glutamic acid. At this condition, the L-glutamic acid melted and
boiled very soon. The colorless liquid changed to pale yellow and brown within
45 s, indicating the carbonization of L-glutamic acid during the pyrolysis. At this
moment, distilled water was added into the brown liquid to dissolve and disperse
the GQDs under vigorous stirring to avoid aggregation. Unlike other methods,
surface passivation agents or other inorganic additives were not needed for the
generation of high quantum yield GQDs. The residue L-glutamic acid could act
as a surface passivation agent, resulting in the extremely stable and highly
fluorescent GQDs in solution. The GQDs were formed in one step of the
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pyrolysis of the precursor. Moreover, the amino group on the L-glutamic acid
surface provided active groups for surface modification of GQDs.

Scheme 2. Schematic diagram of the formation of GQDs through pyrolysis of Lglutamic acid.

Figure 24. (A) The HRTEM image of GQDs with a scale bar of 5 nm. Inset: A typical
single GQD with the lattice parameter of 0.246 nm. The scale bare was 1 nm; (B) The
size distribution of GQDs calculated from more than 100 dots.
3.2. Characterization of the Morphology and Composites of the GQDs.
The morphology of the obtained GQDs was first characterized using a
high resolution TEM (Figure 24A). The high crystallinity of the GQDs was
shown as in the inset of Figure 24A. The GQDs’ lattice space was accurately
measured to be 0.246 nm at the HRTEM image, which is comparable to that of
graphitic.119 The average diameter of the GQDs was 4.66 ±1.24 nm according to
the statistic calculation of more than 100 dots (Figure 24B). The size distribution
showed uniform dimension of the developed GQDs.
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Figure 25. EDS spectra of L-glutamic acid (A) and GQDs (B), and the relative atomic
percentage of L-glutamic acid and GQDs(C).
The element content of the GQDs was analyzed using EDS. As a
control, the relative atomic percentage of L-glutamic acid were 48.73% (C),
9.54% (N), and 41.73% (O) (Figure 25A and C), which was similar to the
theoretically relative atomic percentage of L-glutamic acid (50 % of C, 10 % of
N and 40 % of O). After the pyrolysis of the L-glutamic acid, the GQDs were
formed. Their carbon content increased from 48.73 % to 60.01 %. Meanwhile,
the oxygen content decreased from 41.73 % to 34.60 %, and the nitrogen content
decreased from 9.54 % to 5.39 % (Figure 25B and C). This result indicated that
the L-glutamic acid was carbonized after pyrolysis.
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Figure 26. (A) Raman spectra of GQDs. (B) XRD patterns of GQDs.
To confirm the formation of GQDs XRD pattern and Raman spectroscopy
were used to characterize the product. As shown in Figure 26A, the Raman
spectrum of GQDs has two typical peaks at ca. 1355 cm-1 and 1580 cm-1. The G
band (1580 cm-1) was related to the vibration of the sp2-bonded C atoms in the
graphene materials; and the D band (1355 cm-1) corresponded to the destruction
of the sp2 network by the sp3-bonded C atoms. Figure 26B showed a typical XRD
profile of GQDs. It had a broad (002) peak centered at ca. 20.0°, which is similar
to the GQDs synthesized by other methods.99

Figure 27. (A) FT-IR spectra of L-glutamic acid (a) and GQDs (b). (B) The zeta
potential of GQDs in different pH solutions.
The structural change of the L-glutamic acid during the formation of the
GQDs was further characterized using the FT-IR spectra (Figure 27A).
55

Compared curve a with b in Figure 27A, the C=C stretching of graphite was
formed as indicated by the appearance of the 3000 cm-1 and 1500 cm-1 peaks,
which demonstrated the formation of GQDs.120 The broad peak area from 2500
– 2800 cm-1 was from the carboxylic acid O-H stretch. Meanwhile, the strong
peak from 1600 to 1730 cm-1 resulted from the combination of carboxylic acid
C=O stretch and amide C=O stretch in the GQDs. The carboxylic acid O-H
stretching and C=O stretching peaks demonstrated the presence of the carboxyl
groups. The amide C=O stretching and new formed amide N-H stretching peak
(3700 – 3500 cm-1) indicated the formation of the amides between the amine
group and the carboxyl group. The stretching vibrations of amine N-H (ca. 3360
cm-1) in both curves indicated the presence of amine groups in the L-glutamic
acid and GQDs. The oxygen-containing and nitrogen-containing groups
promised the high water solubility and stability in solution.
The zeta potential of the GQDs in different pH values was also
investigated. As shown in Figure 27B, the zeta potential changed from positive
6.81 mV to negative 23.2 mV by increasing the pH value from 2 to 12. This large
change of the zeta potential with the pH was related to the presence of the amino
and carboxyl groups in the GQDs. Because of the reaction activity of the amino
and carboxyl groups, the biomolecules, such as antibodies and aptamers, could
be easily conjugated onto GQDs for further applications.
3.3. Fluorescence Properties of the GQDs.
The significant feature of the developed GQDs relies on their
fluorescence properties. We have investigated the fluorescence properties using
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Figure 28. (A) The absorption (curve a), excitation (curve b) and emission spectra
(curve c) of GQDs. Inset: from left to right are the GQDs solutions under bright light,
violet, blue and green irradiation, respectively; (B) Fluorescence emission spectra of
GQDs with different excitation wavelengths; (C) - (E) The confocal fluorescence
images of the GQDs under different excitation wavelengths. (C) 359 nm excitation;
DAPI channel; (D) 488 nm excitation, LP 505 nm; (E) 514 nm excitation, BP 530-600
nm.
both the spectroscopy and the microscopy. The obtained UV-vis absorption
spectra and photoluminescence spectra were shown in Figure 28A. The GQDs
showed two obvious absorption peaks at 238 nm and 335 nm, respectively
(Figure 28A, curve a). The peak around 238 nm was attributed to π- π* transitions
of C=C bonds. The apparent peak at 335 nm indicated the major uniform size of
the sp2 clusters in the GQDs even though these sp2 clusters were doped in the sp3
matrix. The color of GQDs in the aqueous solution was yellow (Inset of Figure
28A). When the GQDs were excited at 360 nm (Figure 28A curve b), the GQDs
showed a strong fluorescence peak at 440 nm (Figure 28A curve c). More
importantly, the fluorescence is strong enough to be observed by naked eyes
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(Inset of Figure 28A), which has promising applications for fluorescence
imaging. In addition, the fluorescence emission spectra showed an excitationdependent manner. The emission peak of GQDs shifted from 415 nm (violet) to
580 nm (red) when the excitation wavelength was changed from 320 nm to 540
nm (Figure 28B).
We then investigated the fluorescence property of GQDs using a
fluorescence microscope. With the irradiation of the violet (330-385 nm), blue
(460-500 nm) and green (535-585 nm) light, the GQDs emitted strong blue, green
and red fluorescence, respectively (Figure 28C, D, E). It should be noted that the
precursor of the GQDs showed no absorption in the violet region and no
fluorescence in the range of violet to visible. Thus, all these fluorescence
properties should come from the formation of GQDs.
To further explore the fluorescence features of the developed GQDs, we
measured their fluorescence quantum yield and lifetime. Using fluorescein as a
reference dye the quantum yield of GQDs was measured to be 54.5 % under the
excitation of 360 nm. This relative high quantum yield might be benefited from
the protection of the residue L-glutamic acid as the surface passivation agent.
The fluorescence lifetime of the GQDs was analyzed using the TCSPC method
at different emission wavelengths with 370 nm excitation. All three fluorescence
emissions exhibited well fitted triple-exponential function as shown in Figure 29.
The observed lifetimes of GQDs at 445 nm, 505 nm, 650 nm and 815 nm were
summarized in Table 3. Their average lifetime was in the range of 1.48 to 2.40
ns. The nanosecond lifetime of GQDs demonstrated their potential for
optoelectronic and biological applications.
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Figure 29. Lifetime measurement curves for reference (a) and GQDs at different
emission wavelengths with 370 nm LED irradiation. Emission wavelengths: (b) 445
nm; (c) 505 nm; (d) 650 nm, and (e) 815 nm.
Table 3. Caption Fluorescence lifetime of GQDs at different emission wavelengths
with 370 nm excitation.
Ex (nm)

Em (nm)

τ1 (ns)

τ2 (ns)

τ 3 (ns)

Av. τ (ns)

370

445

0.81

3.64

11.55

2.40

1.14

370

505

3.78

0.80

12.04

2.22

1.27

370

650

2.35

6.77

0.47

1.48

1.13

370

815

3.23

0.47

8.70

1.91

0.97

Chi

Compared to the traditional organic dyes, such as FITC, the GQDs not
only could emit fluorescence at different wavelengths, but also showed much
higher photostability. As shown in Figure 30, the fluorescence of FITC was
bleached by 70 % under a confocal laser within 2 min (Figure 30A, C).
However, the fluorescence of GQDs still showed strong intensity (47 % was
bleached) even after 18 min of the same irradiation (Figure 30B, C). This
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increased photostability provided the GQDs with a great potential for in vitro and
in vivo fluorescence imaging.

Figure 30. Comparison of the photostability of the GQDs with a fluorescent dye
molecule FITC under the irradiation of a confocal laser. A, the confocal fluorescence
images of FITC; B, the confocal fluorescence images of GQDs; C, the photostability of
these two fluorescent materials; D, the effect of pH on the fluorescence intensity of the
GQDs.
We also investigated the stability of the GQDs at different pH values
(Figure 30D). The results showed that at pH 7.0 the GQDs had the highest
fluorescence intensity. In the range of pH 5.0-9.0, the changes of the fluorescence
intensity were less than 1.4 %. This range covered the majority of pH values of
living systems. When the pH value was below 5.0 or higher than 9.0, the
fluorescence intensity of the GQDs was reduced by 32.3 %. The significant
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stability of the GQDs over the broad pH range might come from the surface
amino groups and carboxyl groups, which could resist the pH effect on the
fluorescence intensity of GQDs.

Figure 31. (A) Fluorescence emission spectrum of the GQDs in the visible-NIR region.
(B) NIR fluorescence spectra of the GQDs under different excitation wavelengths. (C)
The NIR fluorescence intensity vs. the concentration of GQDs.
Besides the fluorescence emission in blue, green and red regions, the
GQDs emitted relatively lower NIR fluorescence around 815 nm with the
irradiation of 360 nm. The intensity ratio of 815 nm to 440 nm was 0.2 according
to the fluorescence spectra (Figure 31A). The NIR peak was significantly higher
than the 2 λ diffraction peak as shown in Figure 31B. Similar to the fluorescence
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property in the visible region, the peak in the NIR region showed red shift if the
excitation wavelength became longer (Figure 31B). Meanwhile, the fluorescence
intensity of the GQDs in the NIR region was proportional to the concentration of
the GQDs in the range of 0.468-15.000 mg/mL (Figure 31C). This relationship
indicated that the NIR fluorescence must be attributed to the GQDs even though
the mechanism was not clear yet. Notably, the Stokes shift of this NIR
fluorescence was as large as 455 nm. The large Stokes shift provided the GQDs
with significant advantages for fluorescence bioimaging and biosensing. The
lifetime of the fluorescence at 815 nm with excitation of 370 nm was examined
(Figure 29e). The result showed a similar value to that of the visible fluorescence.
The short lifetime value eliminated the possibility of phosphorescence of the 815
nm peak.
3.4. In Vitro Fluorescence Imaging Using GQDs.
Based on these excellent fluorescence properties, the bioimaging
applications of the fluorescent GQDs were further investigated in vitro and in
vivo. The in vitro fluorescence imaging using the developed GQDs was explored
under different excitation wavelengths. After the GQDs were incubated with
MH-S cells for 1 h, the fluorescence images of the cells were taken using a
confocal microscope. As shown in Figure 32B, the MH-S cells incubated with
GQDs in PBS buffer showed strong green (LP475) and red (LP 530) colors upon
excitation at 458 nm and 514 nm, respectively. However, no apparent
fluorescence was observed from the control group that was not incubated with
the GQDs under the same conditions (Figure 32A). Our results demonstrated that
the GQDs can emit strong fluorescence in the range of green to red for in vitro
fluorescence imaging. The strong fluorescence on the MH-S cells incubated with
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GQDs suggested that GQDs had penetrated into the cells and were able to label
both the cell membrane and the cytoplasm of MH-S cells. The uptake of GQDs
by MH-S cells would be similar to the pathway of nanoparticles, which is
endocytosis.121

Figure 32. Laser scanning confocal fluorescence microscopy images of MH-S cells. (A)
Control MH-S cells without GQDs; (B) the MH-S cells treated with GQDs for 1 hour.
All the scale bars was 20 µm.
3.5. In Vivo Fluorescence Imaging Using GQDs.
The feasibility of the GQDs for in vivo bioimaging was investigated in
mice. A 100 μL aliquot of 25 mg/mL GQDs were injected subcutaneously into
the back of nude mice and intramuscularly into the right back leg. The
fluorescence images of the mice under different excitation and emission filters
were captured. As shown in Figure 33, various excitations from blue to red
centered at 430, 465, 500, 535 and 605 nm were applied for the in vivo
fluorescence imaging. The emission bandpass filters for each excitation
wavelength were illustrated on the top of each image in Figure 33. With the
excitation wavelength increased, all the fluorescence intensity decreased.
Moreover, the detectable fluorescence region had extended with the longer
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excitation and emission wavelengths from the intramuscularly injection spot of
the right back leg. This result demonstrated that the longer wavelengths had
better penetration ability than the short wavelengths for the in vivo fluorescence
imaging. Considering the decreased fluorescence intensity in the longer
wavelengths, the optimal excitation and emission bandpass to obtain the highest
signal-to-background ratio should be investigated in the future for further
imaging applications. Overall, the in vivo fluorescence imaging in mice under
subcutaneous and intramuscular injection indicated that the GQDs could be used
as a fluorescent labeling agent for bioimaging in both visible and NIR regions.

Figure 33. In vivo fluorescence imaging of mice injected GQDs subcutaneously (spot
a) and intramuscularly (spot b). The images were taken under various excitation
wavelengths and emission wavelengths indicated on the top of each image. A 100 µL
aliquot of 25 mg/mL GQDs was injected into each spot. The following emission
bandpass filters were used: GFP: 515-575 nm; DsRed: 575-650 nm; Cy5.5: 695-770
nm.
3.6. Colorimetric Detection of H2O2 Using GQDs.
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Figure 34. UV-vis absorption spectra of the ABTS solution containg a) 9 mM
H2O2; b) 2.7 mg/mL GQDs with 9 mM H2O2; and c) 2.7 mg/mL GQDs. Inset:
The corresponding photographs of these three samples.
To extend the application fields of the GQDs, in addition to the optical
properties, we have investigated the catalytic ability of the GQDs. It was reported
that the materials containing aromatic sp2 carbon clusters had the intrinsic
peroxidase-like catalytic activity to produce a blue color reaction in the presence
of H2O2 and peroxidase substrate, 3,3,5,5-tetramethylbenzidine (TMB). For
example, both carbon nanotubes and graphene sheets were used for the label-free
detection of glucose and single-nucleotide polymorphism through their intrinsic
peroxidase-like catalytic activity.122,
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Inspired by this work, we explored

whether our GQDs could be used for label-free colorimetric sensing as a catalyst.
With the addition of H2O2, the GQDs catalyzed the reduction of hydrogen
peroxide indicated by the color change of the solution to green in the presence of
the peroxidase substrate ABTS (Figure 34 inset). The absorbance change of
ABTS at 416 nm could be used for monitoring the reaction rate and the
peroxidase-like catalytic activity (Figure 34). Compared to the control groups
including the solution without GQDs or H2O2, the signal-to-background ratio was
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higher than 9. Thus, the peroxidase-like catalytic activity of the GQDs would be
used for the detection of H2O2, an important reactive oxygen species in the
biomedical context.
We then optimized the detection conditions for catalyzing H2O2 reaction
using the GQDs. The conditions included pH, reaction temperature, and
concentrations of ABTS and GQDs. The pH value was a critical factor for the
detection of H2O2. It was reported that the optimal pH for a carbon nanoparticle
catalyzed H2O2 reaction was 4.0.124 Our results showed that, in a low pH range
(3.0-5.0), the reaction rate was very stable (Figure 35A). However, the reaction
rate decreased above pH 5.0. Therefore, the pH 5.0 was chosen as the optimal
pH. Meanwhile, the reaction temperature would affect the catalytic reaction rate.
As shown in Figure 35B, high temperature would increase the reaction rate.
Considering normal mammalian body temperature, 37 °C was selected as the
standard condition for analyzing H2O2. Apparently, the ABTS as a substrate
could affect the sensitivity of the colorimetric detection of H2O2. As shown in
Figure 35C, the reaction rate increased as the concentration of ABTS increased
until a concentration of 7.2 mM was reached. Therefore, 7.2 mM of ABTS was
chosen as the optimal concentration. Moreover, the concentration of GQDs was
proportional to the reaction rate (Figure 35D). However, a high concentration of
GQDs would affect the absorption of the ABTS. Therefore, a concentration of
5.40 mg/mL GQDs was chosen as the optimal concentration for the detection.
Under the above optimal conditions, the detection of H2O2 was carried
out using this GQDs-based label-free colorimetric system. As shown in Figure
36A, with the increase of the concentrations of H2O2, the absorbance increased
in a concentration-dependent manner. This assay provided rapid detection (2
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min) of H2O2 with the linear range from 0.1 mM to 10 mM (Figure 36B). The
limit of detection was 20 µM according to the calibration curve at a signal-tobackground ratio of 3. Thus, our studies suggest that the GQDs may have
potential for applications in the biosensing field.

Figure 35. Optimization of the reaction conditions for the detection of H2O2. (A)
pH; (B) temperature; (C) concentration of ABTS; (D) concentration of GQDs.

Figure 36. (A) The relationship of the absorption with the concentrations of H2O2 (from
the bottom to the top: 0, 0.1, 0.2, 0.3, 0.4, 0.5, 1.0, 5.0 and 10.0 mM); (B) The
calibration curve of the label-free colorimetric method for the detection of H2O2.
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4. Conclusions
In conclusion, GQDs with excellent fluorescence properties and peroxidaselike activity were developed using a direct and simple pyrolysis of an amino acid, Lglutamic acid. The GQDs not only showed a stable, strong excitation-dependent
photoluminescence with high quantum yield (54.5 %) in the blue to red range but also
provided an excitation-dependent NIR fluorescence emission around 815 nm. Even
though the mechanism of this NIR fluorescence emission was not well understood, the
application potential of the NIR fluorescence was significant. By using a strong visible
irradiation, the GQDs showed the potential to be used for in vitro and in vivo
fluorescence imaging. Furthermore, the GQDs possessed a peroxidase-like activity
which could catalyze the reduction of H2O2 in the presence of the ABTS substrate.
Using the labelling-free colorimetric method, the GQDs may have broad applications
in detecting H2O2, an important reactive oxygen species in biomedical context.
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CHAPTER V
ONE-POT SYNTHESIS OF REDUCED GRAPHENE OXIDE/METAL (OXIDE)
NANOCOMPOSITES AND ITS APPLICATION FOR ELECTROCHEMICAL
ANALYSIS
1. Introduction
Graphene, a two-dimensional carbon nanomaterial containing a monolayer of
sp2 hybridized carbon atoms, has attracted increasing attention due to its useful
electronic, thermal, and optical properties.125-131 Graphene is usually synthesized by the
modified Hummer’s method, which forms graphene oxide (GO) from graphite with
ultrasonication, afterwards oxygen-containing groups on the GO are treated to form
reduced graphene oxide (RGO). The electrical and thermal conductivity of RGO
exceeds those of GO even though they are still lower than pristine graphene.132-134
However, the residual oxygen-containing groups in RGO (carboxyl, epoxy, carbonyl,
and hydroxyl) provide active sites for further chemical modification and decoration
with other nanomaterials, thereby allowing electronic and optoelectronic properties to
be tailored.135, 136 When modified with inorganic nanomaterials (e.g., Au, Cu, Ag,
TiO2, Fe3O4, QDs, SiO2, and etc.), graphene has found numerous applications in fields
such as solar energy storage,137 Li-ion battery fabrication,138-140 biosensors,141-144 and
drug delivery.145-148 For instance, Xu et al. adsorbed metal nanoparticles (Au, Pt and
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Pd nanoparticles) on the surface of GO followed by reduction of GO to RGO
using ethylene glycol.149 The resulting graphene-Pt composites showed promise in
direct methanol fuel cells. Lightcap et al. anchored semiconductor and metal
nanoparticles on RGO at separate sites.150 With UV irradiation, the photogenerated
electrons from TiO2 were captured and transferred through RGO to reduce silver ions
to silver nanoparticles apart from TiO2. This electron storage and shuttling ability of
RGO demonstrated its potential use as a catalytic nanocomposite.
In general, there are two different pathways to fabricate graphene-inorganic
nanocomposites including ex situ hybridization and in situ decoration.131 In the process
of ex situ hybridization, the inorganic nanoparticles are synthesized separately from
graphene using traditional methods. Afterwards, the well-defined inorganic
nanoparticles are adsorbed onto the surface of RGO through either covalent or noncovalent binding. This method ensures better shape and size control of the inorganic
nanoparticles. Meanwhile, surface modification of inorganic nanoparticles can be
easily conducted prior to their hybridization with RGO. However, all the inorganic
nanoparticles should be prepared in advance for ex situ hybridization, which
complicates the preparation process. Also, loading efficiency of the inorganic
nanoparticles on RGO is usually lower than in situ methods. Accordingly, in situ
methods for the fabrication of RGO-inorganic nanocomposites have received
increasing attention.151-153
Several inorganic nanoparticles, especially metallic nanoparticles have been
decorated on the surface of GO or RGO using in situ methods.154-156 Usually, the metal
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precursors are added directly to the graphene materials for a one-pot synthetic method
that dramatically simplifies the synthetic process. The oxygen-containing groups in GO
and RGO provide nucleation sites for crystallization of the metal nanoparticles.135, 136
Meanwhile, with the introduction of reducing agents, the metal precursors and GO
could be simultaneously reduced in solution.157 However, two main limitations of these
in situ methods are (i) the unstable dispersion of RGO in aqueous solutions due to the
removal of oxygen-containing groups and (ii) the use of toxic reducing agents (e.g.,
hydrazine and sodium borohydride). To improve stability of the RGO-inorganic
nanocomposites, surfactants and polymers can be adsorbed to the surface of RGO prior
to the reducing process.158-160 To avoid toxic reducing agents, biocompatible reagents,
such as ascorbic acid,157 glucose,161 sodium citrate162 and ethylene glycol,163 can be
used to reduce GO and metal precursors. However, in most of these methods, an extra
stabilizer is usually needed to disperse the resulting RGO-inorganic nanocomposites in
solution. Therefore, a general simple in situ method to decorate RGO with inorganic
nanocomposites is needed.
The present work demonstrates a generalized, environmental-friendly in situ
method for fabrication of RGO-metal (oxide) nanocomposite materials. The
environmentally benign reagent, glucose, was found synthetic to be an especially
effective reductant and solution stabilizer in the one-pot process. Moreover, the process
was found to be adaptable for synthesizing a variety of RGO/metal (oxide)
nanocomposites,

including

RGO/Au,

RGO/Cu2O

and

RGO/Ag.

Extensive

characterizations were used to confirm the composition and morphology of the
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designed nanocomposites. Furthermore, the electrocatalytic activity of the RGO/Au
nanocomposite was demonstrated with the simultaneous analysis of L-ascorbic acid (LAA), dopamine (DA) and uric acid (UA) under physiological solution conditions. This
result illustrated the potential of the developed nanocomposites for other biomolecule
detection schemes.
2. Experimental Section
2.1. Materials.
Graphene oxide was purchased from Cheap Tubes Inc., VT. Glucose (≥99.5%,
GC grade), L-ascorbic acid (L-AA, ≥99.0%, crystalline), dopamine hydrochloride
(DA), uric acid (UA, ≥99%, crystalline), chloroaunic acid tetrahydrate (+ 99.9%),
copper(II) chloride dehydrate (ACS reagent, ≥99.0%), silver nitrate (ACS reagent,
≥99.0% ) and ammonium hydroxide (ACS reagent, 28.0 %) were purchased from
Sigma Aldrich Inc. Phosphate buffered saline tablets and fetal bovine serum were
purchased from Fisher Scientific. Deionized (DI) water (Millipore Milli-Q grade) with
resistivity of 18.2 MΩ•cm was used in all experiments.
2.2. Preparation of RGO/Metal (Oxide) nanocomposites.
The RGO/metal (oxide) nanocomposites were prepared using a one-pot
reaction. In brief, 160.0 mg glucose was added to a stirred homogeneous GO solution
(100.0 mL, 5.0 mg) and stirred for 30 min. An 80 µL aliquot of NH4OH (28.0 %) was
added quickly to the solution and the flask was heated to boiling for 20 min. During
this time, the color of the solution changed from brown-yellow to dark black, indicating
the formation of RGO from GO. Afterwards, 1.0 mL of the metal precursor solution
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(1.0 % HAuCl4, 1.0 % CuCl2 or 0.5 % AgNO3) was added drop wise and the mixture
was boiled for 15 min. Finally, the cooled dispersed solution was centrifuged to separate
the unattached metal nanoparticles that remained suspended in the supernatant during
the centrifugation. The RGO/metal nanocomposite precipitate was redispersed into
20.0 mL Milli-Q water with sonication for further usage.
2.3. Characterization.
The scanning transmission electron microscopy (STEM) and scanning
electron microscopy (SEM) images of RGO/metal (oxide) nanocomposites were
obtained with a Hitachi SU8010 field emission scanning electron microscope.
Elemental analysis for different RGO/metal nanocomposites was performed by an
energy-dispersive X-ray spectroscope (EDS) (Oxford, X-Max) installed in the Hitachi
SU8010 SEM. X-ray diffraction (XRD) profiles were obtained with a Bruker AXS D8
advanced powder X-ray diffraction system using Cu Kα radiation. Raman spectra were
obtained with an Aramis labRAM Raman spectrometer (Horiba JobinYvon) using a
helium-neon laser at 542 nm. Fourier transform infrared (FTIR) spectra were obtained
with a FT-IR spectrometer (Spectrum 400, PekinElmer) and UV-vis absorption spectra
were recorded with a Shimadzu UV-250 spectrometer.
2.4. Electrochemical Measurement.
All cyclic voltammetry (CV) and differential pulse voltammetry (DPV) were
performed with an Autolab PGSTAT302 potentiostat using a standard three-electrode
cell. The cell was configured in all experiments with a Ag/AgCl (saturated KCl)
reference electrode, a platinum wire counter electrode, and a modified glassy carbon
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electrode (GCE, 5 mm diameter, BASi). Prior to the medication, the GCE was cleaned
by polishing with an aqueous suspension of 0.05 µm alumina powders (Buehler),
rinsing with DI water under sonication and then electrochemical cycling in 1.0 M
H2SO4 from - 0.4 V to 1.5 V until a stable CV was obtained. After rinsing and drying
the cleaned electrode, a 20 μL aliquot of GO, RGO or RGO/Au nanocomposites was
drop-cast onto the GCE surface and dried in a 60°C oven for 30 min.
CV and DPV measurements of L-AA, DA and UA were performed at room
temperature with a 0.01 M pH 7.0 PBS buffer and usually containing 10-times diluted
serum to model physiological conditions. The DPV analysis was conducted with L-AA,
DA and UA stock solutions spiked into the PBS buffer with diluted serum.
3. Results and Discussion
3.1. Design and Synthesis of the RGO/Metal (Oxide) Nanocomposites.
The designed one-pot synthetic process for RGO/metal (oxide) nanocomposite
was shown in scheme 3. This method has three main features. First, the reductant used
in the synthetic process is environmental friendly, by being natural and non-toxic.
Secondly, the reductant plays multiple roles in the synthetic process as a reducant for
both GO and metal precursors and as a stabilizer for protection of the product from
aggregation. Thirdly, this synthetic method is general enough to produce different types
of RGO/metal (oxide) nanocomposites. The rational of selection of glucose as the
reductant is based on its natural and nontoxic properties as well as its abundance and
relatively gentle activity. Other natural substances, such as sucrose, fructose and Lascorbic acid, have also been used for the reduction process.161, 164 However, glucose
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has already been proven to be useful for the reduction of GO.161 After reducing GO,
glucose is oxidized to gluconic acid that has also been used as a stabilizer to remain
RGO stable in aqueous solution.161 Meanwhile, glucose has been used for the synthesis
of gold and silver nanoparticles.165 Inspired by these works, we developed the one-pot
approach was developed for the synthesis of RGO/metal (oxide) nanocomposites using
glucose as the multi-functional reducing agent and stabilizer precursor as shown in
scheme 3.
(1)

(A)

(B)

(C)

Scheme 3. Illustration of the synthetic process of RGO/metal (oxide) nanocomposites
using glucose as the reducing agent. (A) GO was stirred with glucose without heating;
(B) GO was reduced to form RGO by glucose with boiling for 20 min; (C) RGO/Au
nanocomposite was formed through the injection of HAuCl4 in (B) for boiling another
15 min.
In Scheme 3, the oxygen-containing groups on GO, such as carboxyl and
hydroxyl groups, were removed under thermal treatment with an excess of glucose as
the reducing agent. The color of the solution changed from brown-yellow (Scheme 3A)
to dark black (Scheme 3B) indicated the formation of the RGO from GO. In literatures,
RGO was reduced by other methods, including thermal treatment and chemical
reduction, which suffered from unstable suspension because most of the oxygen75

containing groups were removed from GO and electrostatic repulsion between the RGO
sheets decreased significantly. In contrast, RGO reduced by glucose was more stable in
water suspension due to the protection of gluconic acid on the surface of RGO.161
Moreover, the gluconic acid and residual oxygen groups on RGOs provided reactive
sites for absorption and nucleation of different metal ions onto the surface of RGO,
followed by reduction of metal ions to form the nanoparticles on these sites (Scheme
3C). The color of the solution changed with the addition of metal precursors, indicating
the formation of different metal (oxide) nanoparticles on the surface of RGOs. The
resulted RGO/metal (oxide) nanocomposites required several centrifugation/washing
cycles with DI water to ensure separation of dispersed metal nanoparticles from the
nanoparticle-decorated RGOs.
3.2. Characterization of Designed Nanocomposites.
Nanocomposites were characterized with a number of methods including
imaging, elemental analysis, and spectroscopies.
3.2.1. Morphology and elemental analysis of the developed nanocomposites.
Successful decoration of different metal (oxide) nanoparticles onto RGOs was
demonstrated by STEM images (Figure 37, images of 1 series) and SEM images (Figure
37, images of 2 series). First, before the reaction, the pure GO was imaged (A1 and A2).
The both STEM and SEM images clearly showed GO sheet structures. After the
reaction with glucose, little difference can be observed (B1 and B2) compared to A1 and
A2, although spectroscopy results described in the next section confirmed the distinct
oxidation state of RGO. When an addition of different metal precursors were added to
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the RGO, the images clearly showed metal or metal oxide nanoparticles nanoparticles
formed on the RGO surface (Figure 37 C-E). Specifically, an addition of HAuCl4
yielded 45.3 ± 0.8 nm gold nanoparticles which fully coated RGO (Figure 37 C1 and
C2). The energy dispersive X-ray (EDS) analysis of this sample in Figure 37C indicated
that the nanoparticles were Au (Figure 38A). to test the universal potential of this
phenomenon to other metal elements, an Ag precursor (AgNO3) was added to the RGO
solution. As expected, the RGO surface was successfully decorated with Ag
nanoparticles (Figure 37 D1 and D2), and the EDS spectra indicted the presence of
element of Ag (Figure 38B). In addition to the formation of pure metal nanoparticles,
some metal oxide nanoparticles could be produced on the RGO surface. We treated
RGO solution with a copper precursor (CuCl2). The nanoparticles were also produced
(Figure 37 E1 and E2). However, the elemental analysis (Figure 38 C) of the
nanoparticles was significantly distinct from Au and Ag. In Figure 38C, the atomic ratio
of oxygen to carbon was 2.33:1 in RGO/Cu2O nanocomposite, which was higher than
the other two metals (2.11:1 and 2.05:1 for RGO/Au and RGO/Ag, respectively),
indicating the possible formation of copper (I) oxide nanoparticles instead of copper
nanoparticles.
SEM images showed that metal and metal oxide nanoparticles on each side of
RGO could be easily distinguished based on their different contrast. Wrinkles of the
RGO could be recognized especially from the area with nanoparticles. It seems that the
nanoparticles were trapped within the RGO sheet. Average diameters of these
nanoparticles were statistically calculated from the measurements of multiple
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nanoparticles (N > 50). The results were 45.3 ± 0.8 nm (Au), 53.4 ± 0.9 nm (Ag) and
675.1± 9.2 nm (Cu2O). Overall, the above results demonstrated that different metal
(oxide) nanoparticles could be decorated on the surface of RGO during the in situ
reduction process using glucose as a reductant.

Figure 37. The STEM (A1, B1, C1, D1 and E1) and FE-SEM (A2, B2, C2, C2, D2 and E2)
images of GO (A1 and A2), RGO (B1 and B2), RGO/Au (C1 and C2), RGO/Ag (D1 and
D2) and RGO/Cu2O (E1 and E2) nanocomposites. Reaction conditions: 100.0 mL GO
solution (0.1 mg/mL), 160.0 mg of glucose, and 80 µL NH4OH were mixed to form a
homogenous solution. The solution was boiled for 20 min followed by the addition of
1.0 mL metal precursors for another 15 min of boiling.
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Figure 38. EDS of RGO/Au (A), RGO/Ag (B) and RGO/ Cu2O (C) nanocomposites.
Reaction conditions: 100.0 mL GO solution (0.1 mg/mL), 160.0 mg of glucose, and 80
µL NH4OH were mixed to form a homogenous solution. The solution was boiled for
20 min followed by the addition of 1.0 mL metal precursors for another 15 min of
boiling.
3.2.2. Spectroscopic characterizations.
We further confirmed the developed nanocomposites using UV-vis spectra,
FTIR, Raman spectra and XRD. First, we investigated their UV-vis spectra (Figure
39A). UV-vis absorption spectrometry is a powerful tool to distinguish the GO from
RGO since they were hard to be differentiated from the previous microscopic images.
It should show a red shift on the absorption peak if GO becomes RGO according to the
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literature.157 In our result, the pure GO showed a typical absorption peak at 230 nm
(Figure 39A curve a). After 20 min of reaction with glucose, the 230 nm absorption
peak was shifted to 260 nm (Figure 39A curve b). This peak shift was an indication of
the change from GO to RGO. The formation of metal (oxide) nanoparticles on the RGO
can also be confirmed from their UV-vis absorption spectra. After the reaction with the
metal precursors, RGO remained its original absorption peak at 260 nm. Meanwhile, a
second absorption peak appeared at 560 nm for Au (Figure 39A curve c), which was
corresponded to the red color of the RGO/Au nanocomposite. Similar to the RGO/Au
nanocomposite, an absorption peak at 425 nm was formed for Ag (Figure 39A curve
e), which was assigned to the color of yellow. However, the copper-based
nanocomposite showed no second absorption peak (Figure 39A curve d), although the
resulted RGO/Cu2O nanocomposite appeared a light blue color in solution. which was
probably due to the overlap of RGO absorption. The reduction of GO to RGO was
further confirmed by other three spectroscopic methods below.
We then performed FTIR spectrometry to further confirm the reduction of GO
to RGO (Figure 39B). As a control, first, the pure glucose’s the FT-IR spectrum of
glucose (Figure 39B curve a). Compared to the pure glucose, GO showed a strong
infrared absorption band at 1725 cm-1 due to C=O stretching (Figure 39B curve b).
When the GO was reduced by glucose, this peak decreased significantly while the C=C
stretching peak at 1620 cm-1 appeared (Figure 39B curve c). The peak shift from C=O
to C=C indicated the reduction of GO to RGO. Furthermore, we tested Au, Ag and
Cu2O decorated RGO. As shown in Figure 39B curves d, e, and f, their FT-IR spectra
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clearly showed C=C peak around 1620 cm-1 but the C=O peak at 1725 cm-1were not
visible. The FT-IR spectrometry results supported the reduction of GO to RGO by
glucose.
A

B

D

C

Figure 39. (A) Absorption spectra, of GO (a), RGO (b), RGO/Au (c), RGO/Cu2O (d)
and RGO/Ag (e) nanocomposites. (B) FT-IR spectra of glucose (a), GO (b), RGO (c),
RGO/ Cu2O (d), RGO/Au (e) and RGO/Ag (f) nanocomposites. (C) Raman spectra of
GO (a), RGO (b), RGO/Au (c), RGO/ Cu2O (d) and RGO/Ag (e) nanocomposites.
(D) XRD patterns of GO (a), RGO (b), RGO/Au (c), RGO/ Cu2O (d) and RGO/Ag
(e) nanocomposites. Reaction conditions: 100.0 mL GO solution (0.1 mg/mL), 160.0
mg of glucose, and 80 µL NH4OH were mixed to form a homogenous solution. The
solution was boiled for 20 min followed by the addition of 1.0 mL metal precursors for
another 15 min of boiling.
Raman spectra further demonstrated different structural signatures between
GO and its reduced products by glucose (Figure 39C). In general when GO is reduced
to RGO, one of the typical structure changes is to form sp2 domain structure. The
change could be evidenced by the increased intensity ratio of the D band at 1350 cm-1
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to the G band at 1595 cm-1 (ID/IG). As shown in Figure 39C, the ratio of ID to IG was
0.92 for the pure GO (Figure 39C curve a); however, the ratio was increased to 1.04
after the glucose was used to reduce the GO (Figure 39C curve b). The 13% increase in
the ratio of ID to IG indicated the formation of RGO. We then tested the Au, Cu2O and
Ag nanoparticles decorated RGO (Figure 39C curve c, d and e). All these samples
showed apparent D and G bands for which the ratios of ID to IG were 1.03, 1.08 and
1.03, respectively. These results demonstrated that GO had been reduced by glucose
and formed a more sp2-like ordered structure.
Structures of GO, RGO, RGO/Au, RGO/Cu2O and RGO/Ag nanocomposites
were further characterized using powder XRD (Figure 39D). GO showed a graphitic
diffraction peak at 11.5°(curve a), corresponding to an interlayer d-spacing of 0.73 nm.
Compared to 0.34 nm of d-spacing of pristine graphite (0.34 nm)161, the larger dspacing distance indicated that the oxygenated functional groups were introduced into
the carbon sheet. The the peak at 11.5°disappeared and a bump around 20°formed for
the newly formed RGO (Figure 39D curve b), which demonstrated the removal of the
oxygen-containing groups from GO and exfoliation of the layered RGO. Once metal
(oxide) nanoparticles were introduced on the surface of the RGO, their corresponding
peaks were evident. For example, RGO/Au (Figure 39D curve c) showed the peaks at
38.4°, 44.2°, and 64.7°which can be assigned to (111), (200) and (220) faces of the Au
nanoparticles. RGO/Cu2O and RGO/Ag also showed characteristic peaks at 29.5°,
36.3°and 38.1°42.2°, 64.5°and 77.5°, respectively, (Figure 39D curve d and e), which
were coincided to their XRD patterns in the literatures.166-168
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The above characterization results have confirmed our design that the GO has
been reduced to RGO and then different types of metal (oxide) nanoparticles decorated
on the surface of the produced RGO. Afterwards, we optimized the synthetic conditions
for making RGO/metal (oxide) nanocomposites. RGO/Au nanocomposite was chosen
as an example for this optimization.
3.3. Optimization of Nanocomposite Synthesis.
Various experimental conditions would affect the formation of RGO/Au
nanocomposites. Here, we investigated a few important conditions that may play crucial
roles for the formation of the designed nanocomposites.
3.3.1 Effect of glucose.
As the solo reductant and stablizer, glucose played an important role in the
synthesis. Therefore, we investigate the effect of glucose on the formation of
nanocomposite. First, glucose acted as a reductant for the generation of both gold
nanoparticles and RGO. Thereafter, glucose served as a stabilizer for RGO and
RGO/Au nanocomposite. We repeated the synthetic process without addition of any
glucose to observe the resulted product. It was found that the absorption peak of GO at
230 nm still existed in either solution before (Figure 40A, curve a) and after (Figure
40A, curve b) the addition of HAuCl4. However, there was no peak appeared at 260 nm
which attributed to RGO. This implied that GO was not reduced without the addition
of glucose. Interestingly, after the addition of HAuCl4, red colored gold nanoparticles
was still formed, with the absorption peak at 538 nm (Figure 40A, curve b). SEM image
showed that all the gold nanoparticles were anchored to the surface of GO (Figure 40B).
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However, compared with Figure 37C1 and C2, less gold nanoparticles were coated on
to the surface of GO, which might be due to the loss of glucose on GO.

Figure 40. (A) Absorption spectra of GO (curve a) and GO/Au nanocomposite (curve
b) without glucose addition. (B) SEM images of the GO/Au nanocomposites without
addition of glucose. (C) Photographs of aqueous dispersions of 0.05 mg/mL GO (a),
RGO reduced by glucose (b), RGO/Au nanocomposites (c) and RGO reduced by the
hydrazine hydrate (d). Solution (a), (b) and (c) were stored for about 3 months. Solution
(d) was stored for 1 day.
We then studied the function of glucose as a stabilizer to protect RGO from
aggregation. As shown in Figure 40C, GO, RGO and RGO/Au nanocomposite reduced
by glucose were stable in aqueous solution for more than 3 months (Figure 40C, a, b
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and c). Usually, GO was reduced by the strong reductant, such as hydrazine hydrate.
However, the instability of RGO reduced by hydrazine hydrate limited their
applications in analysis. Therefore, we synthesized RGO using hydrazine hydrate as a
control. The result showed that the RGO reduced by hydrazine hydrate was not stable.
It started aggregation quickly. As shown in Figure 40C (d), the RGO totally precipitated
in one day. This is significantly different than that three month-stable RGO obtained
using glucose as a stabilizer.
3.3.2. Effect of glucose-to-HAuCl4 ratio.
The amount of glucose and precursor added into the reaction will certainly
affect the resulting product. To better investigate their effect, we choose to study the
effect of glucose-to-HAuCl4 ratio instead of their absolute amount. With a fixed
concentration of GO at 0.2 mg/mL, we adjusted the glucose-to-HAuCl4 mass/volume
ratio from 1.60/1 g/mL, 0.32/1 g/mL, 0.16/1 g/mL, to 0.10/1 g/mL during the synthesis
process. The concentration of the added HAuCl4 was 1.0%. After collecting the
resulting products through centrifugation, each product was characterized with SEM.
As shown in Figure 41, the size of gold nanoparticles on RGO was similar for each
sample, which is around 45.3 ± 0.8 nm. However, the coverage on RGO surface
increased with more HAuCl4 addition, which was illustrated by the increased numbers
of bright spots on RGO in the SEM images from Figure 41A to C. The difference
between Figure 41C and D was insignificant. Both images showed high coverage with
almost every corner of RGO covered, indicating the saturation of the gold
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nanoparticles. In the following experiments, the 0.16/1 (g/mL) ratio of glucose-toHAuCl4 composition (Figure 41C) was chosen as the optimum condition.
3.3.3. Effect of glucose-to-GO ratio.
The effect of amount of glucose should also be considered from its relative
amount to GO. With a fixed ratio of glucose-to-HAuCl4 as 0.16/1 (g/mL), the effect of
glucose-to-GO ratio on the final RGO/Au nanocomposite was investigated (Figure 42).
We changed the glucose-to-GO mass ratio from 32/1, 16/1, to 8/1. It was found on the
SEM images that the diameter of the gold nanoparticles on RGO decreased from 45.3
±0.8 nm to 29.5 ±4.7 nm and 25.5 ±0.6 nm as the glucose-to-GO ratio was decreased
from 32/1 to 16/1 mg and 8/1, respectively. By fixing the concentration of HAuCl4,
increased amount of GO would provide more binding sites for gold ions to anchor.
Therefore, this might decrease the diameter of single gold nanoparticles on RGO.

Figure 41. SEM images of the RGO/Au nanocomposites with different glucose-toHAuCl4 ratios. (A) 1.60/1, g/mL; (B) 0.32/1, g/mL; (C) 0.16/1, g/mL; and (D) 0.10/1,
g/mL. The concentration of HAuCl4 was 1.0 %. The amount of GO was fixed at 20.0
mg.
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Figure 42. SEM images of the RGO/Au nanocomposites with different glucose-to-GO
ratios. (A) 32/1; (B) 16/1; (C) 8/1. The amount of 1.0 % HAuCl4 was fixed at 1.0 mL.
3.4. Electrochemical Detection of L-AA, DA and UA using a RGO/Au-Modified GCE
as a Catalyst.
L-AA, DA and UA play important roles in physiological processes of the
human metabolism.169, 170 Several disease states and disorders can be monitored by
measuring the levels of these biomolecules under physiological conditions.171-173
However, electrochemical detection through direct oxidation of these biomolecules is
difficult with conventional carbon electrodes because of the sluggish and irreversible
nature of these couples. Moreover, oxidation peaks of these three biomolecules occur
at similar potentials, often resulting in an undistinguishable overlap when they are
detected simultaneously. Modification of carbon electrodes with nitrogen-doped
graphene, chitosan, carbon nanotube and gold nanoparticles improves the
electrochemical oxidation of these three biomolecules and has provided a reliable
means for their simultaneous detection.174-178 This improved performance has been
especially true for a variety of recently developed gold nanomaterials. However, by
coupling RGO with gold nanoparticles, the electrochemical analytical performance
might be improved because of the large surface area and high conductivity of RGO.
Meanwhile, RGO could provide a platform for gold nanoparticles to anchor on the
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surface of electrode without other assistant molecules, like chitosan. Accordingly, we
have investigated the electrocatalytic activity of our RGO/Au nanocomposite toward
oxidation of L-AA, DA and UA, followed by the simultaneous detection of these
biomolecules under physiological conditions.
3.4.1. Electrochemical activity of RGO/Au nanocomposites.
RGO has been widely used for electrochemical sensing due to its improved
conductivity after reduction. Meanwhile, metal (oxide) nanoparticles have shown some
electrocatalytic activity for the detection of biomolecules. Therefore, we evaluated the
application of RGO/Au nanocomposites for the electrochemical detection of
biomolecules.
3.4.2. L-AA detection.
The electrochemical behavior of L-AA in 0.01 M PBS (pH 7.0) at a bare GCE,
GO-GCE, RGO-GCE and RGO/Au-GCE was investigated using CV and DPV. As
shown in Figure 43A, the L-AA oxidation was chemically irreversible with an anodic
peak that changed significantly in shape and potential with different electrode
modifiers. Bare GCE and GO-modified GCE yielded broad peaks at rather positive
potentials (> +0.3 V) consistent with sluggish electron transfer. By comparison, the
oxidation peaks with RGO- and RGO/Au-modified GCE were shifted to a much lower
potential (ca. 0 V). The RGO/Au-modified GCE (Figure 43A, curve d) yielded a
particularly narrow peak (Ep-Ep/2 ca. 70 mV) and enhanced peak current. These
characteristics are consistent with electrocatalysis of the L-AA oxidation noted for other
types of gold-modified electrodes.179 They also provide an enhanced signal for L-AA
88

detection. To evaluate the sensitivity of the RGO/Au-modifier for detection of L-AA,
DPV was used for concentrations of L-AA ranging from 0.1 to 2.2 mM in 0.01 M PBS.
As shown in Figure 37C, background-subtracted peak oxidation current (I’pa) was
centered near 0 V and increased linearly below 1 mM with a sensitivity of 4.234
µA/mM (R2 = 0.9973) L-AA (Figure 43D).

Figure 43. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/AuGCE (d) in 0.01 M PBS (pH 7.0) containing 1 mM L-AA. Scan rate: 50 mV/s; (B) Plot
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in 0.01 M PBS
(pH 7.0) containing 1 mM L-AA; (C) DPV curves of RGO/Au-GCE in 0.01 M PBS
(pH 7.0) containing different concentrations of L-AA (0.1, 0.2, 0.4, 0.6, 0.8 and 1.0
mM); (D) Plot of oxidation currents versus different concentration of L-AA at -0.014
V. I: oxidation peak current in the presence of L-AA; I0: oxidation peak current in the
absence of L-AA. Inset shows: the calibration curve of oxidation peak current response
versus concentration of L-AA in the linear range of 0.1 - 1.0 mM.
3.4.3. DA detection.
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The CV and DPV behaviors of the RGO/Au-GCE for the DA detection were
also investigated. As shown in Figure 44A, RGO/Au-GCE showed the highest peak
currents compared to bare GCE, GO-GCE, and RGO-GCE, which indicated that the
RGO/Au-GCE had the better catalytic activity and higher surface area (Figure 44A, d).
Different from the CV behavior of L-AA (Figure 43A) and UA (Figure 45A), the DA
showed a more chemically reversible process on the surface of

Figure 44. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/AuGCE (d) in 0.01 M PBS (pH 7.0) containing 160 µM DA. Scan rate: 50 mV/s; (B) Plot
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in 0.01 M PBS
(pH 7.0) containing 80 µM DA; (C) DPV curves of RGO/Au-GCE in 0.01 M PBS (pH
7.0) containing different concentrations of L-AA (1.0, 2.5, 5.0, 10.0 and 20.0 µM); (D)
Plot of oxidation currents versus different concentration of DA at 0.160 V. I: oxidation
peak current in the presence of DA; I0: oxidation peak current in the absence of DA.
Inset shows: the calibration curve of oxidation peak current response versus
concentration of DA in the linear range of 1.0-20.0 µM.
RGO/Au-GCE. The anodic and cathodic peak currents were related to the square root
of scan rate (Figure 44B), which showed that the electrochemical reaction of DA on the
RGO/Au-GCE was a diffusion-controlled process. The sensitivity for DA detection was
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investigated with RGO/Au-GCE using DPV. As shown in Figure 44C and D, the
current at ca. 0.16 V increased with the addition of DA in 0.01 M PBS. The oxidation
peak current of DA was linear to the DA concentration at RGO/Au-GCE with a linear
function (I-I0) = 0.6277 CDA + 0.1272 (R2 = 0.9897) in the range of 1.0 to 20 µM.

Figure 45. (A) CVs of the bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/AuGCE (d) in 0.01 M PBS (pH 7.0) containing 200 µM UA. Scan rate: 50 mV/s; (B) Plot
of oxidation peak of RGO/Au-GCE versus square root of the scan rate in 0.01 M PBS
(pH 7.0) containing 200 µM UA; (C) DPV curves of RGO/Au-GCE in 0.01 M PBS
(pH 7.0) containing different concentrations of L-AA (5, 10, 20, 40, 80 and 120 µM);
(D) Plot of oxidation currents versus different concentration of UA at 0.290 V. I:
oxidation peak current in the presence of UA; I0: oxidation peak current in the absence
of UA. Inset shows: the calibration curve of oxidation peak current response versus
concentration of UA in the linear range of 5-120 µM.
3.4.4. UA detection.
The same process was carried out for the detection of UA using RGO/Au-GCE
in 0.01 M PBS. As shown in Figure 45, UA showed an oxidation peak potential at ca.
0.32 V, which is a more negative potential than that for bare GCE and GO-GCE, and
with the highest peak current. Similar to the electrochemical behavior of L-AA and DA,
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UA showed a linear relationship between the oxidation peak current and the square root
of scan rate (Figure 45B). The DPV peak current of UA was linear to the UA
concentration at RGO/Au-GCE with a linear function (I-I0) = 0.164 CUA + 0.1863
(R2=0.9866) in the range of 5-80 µM (Figure 45C and D).
3.4.5. Simultaneous determination of L-AA, DA and UA.
Based on the above results for the detection of L-AA, DA and UA, the
RGO/Au-GCE showed great potential for the simultaneous detection of these three
biomolecules. The oxidation peak potential differences for L-AA/DA, DA/UA, and LAA/UA were 200 mV, 150 mV, and 350 mV, respectively. Peak separations of their
magnitude are generally sufficient for simultaneous analysis. Therefore, we
investigated the simultaneous oxidatin of the L-AA (2.2 mM), DA (160 µM) and UA
(200 µM) using DPV with different electrodes. As shown in Figure 46A, bare GCE
showed only one peak that was the overlap of DA and UA. GO-GCE showed two peaks
for DA and UA, which are more positive than that from RGO-GCE and RGO/Au-GCE,
but still no peak for L-AA was observed. RGO-GCE and RGO/Au-GCE were able to
discriminate these three analytes. However, the peak currents for RGO/Au-GCE were
higher than that of RGO-GCE, and the peak potential difference between DA and UA
for RGO-GCE was smaller than that of RGO/Au-GCE. This result indicated that the
Au nanoparticles and RGO all played important roles on the electrochemical catalytic
activity for the simultaneous detection of L-AA, DA and UA. Two combinations of
different concentrations of L-AA, DA and UA were also investigated with RGO/AuGCE using DPV. As shown in Figure 46B, the peak currents for each molecule
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increased when the concentrations of these three analytes increased. Therefore,
RGO/Au-GCE showed a great potential for the simultaneous detection of L-AA, DA
and UA.

Figure 46. (A) DPV curves at bare-GCE (a), GO-GCE (b), RGO-GCE (c) and RGO/AuGCE (d) in 0.01 M PBS (pH 7.0) containing 2.2 mM L-AA, 160 µM DA, and 200 µM
UA; (B)DPVs curves at RGO/Au-GCE in 0.01 M PBS (pH 7.0) containing different
concentrations of L-AA, DA and UA. (a) 0.6 mM L-AA, 10 µM DA, 20 µM UA; (b)
1.2 mM L-AA, 20 µM DA, 40 µM UA.

93

Figure 47. (A) DPV curves of the RGO/Au modified GCE in 10-times diluted serum
containingg individual concentration of AA, DA and UA mixture. [L-AA]: 0.2, 0.4,
0.8, 1.2, and 1.6 mM. [DA]: 1.0, 2.0, 4.0, 6.0 and 8.0 µM. [UA]: 5.0, 10.0, 20.0, 40.0
and 60.0 µM. The calibration curves for L-AA (B), DA (C) and UA (D) in the 10-times
diluted serum.
3.4.6. Reproducibility.
Using L-AA as a model, a series of repetitive measurements were carried out
in 1.0 mM L-AA solution to demonstrate the reproducibility of the RGO/Au-GCE. The
results of nine measurements showed a relative standard deviation (RSD) of 3.41%,
indicating excellent reproducibility for the RGO/Au-GCE.
3.4.7. Complex sample analysis.
To explore the use of a RGO/Au-GCE for practical application, the electrode
was used to detect the three species in fetal bovine serum samples. The fetal bovine
serum was diluted 10 times with 0.01 M PBS (pH 7.0) and then spiked with certain
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amounts of L-AA, DA and UA. As shown in Figure 47A, the peak currents for each
analyte increased with the increased concentrations. Compared to the plot for buffer
alone, the peak potential for each analyte was shifted to more negative values, which
might be due to the complex matrix of the serum samples. However, for all the analytes,
the RGO/Au-GCE showed a response range and high performance linear range (Figure
47B, C and D). The results indicated that the RGO/Au-GCE can be used for the
sensitive simultaneous determinations of L-AA, DA and UA in the real samples.
4. Conclusion
A one-pot synthetic method was developed for the fabrication of RGO/metal
(oxide) nanocomposites using glucose as a reducing agent for both GO and metal
(oxide) nanoparticles. With this simple method, RGO/Au, RGO/Cu2O, and RGO/Ag
nanocomposites were easily produced. Different characterization methods successfully
demonstrated the formation of RGO/metal (oxide) nanocomposite. Using RGO/Au as
a model, we found that the coverage and size of gold nanoparticles on RGO were
affected by the glucose-to-HAuCl4 ratio and glucose-to-GO ratio, respectively.
Furthermore, with the high electrochemical catalytic activity of RGO/Au
nanocomposites, the electrochemical behaviors of L-AA, DA and UA were investigated
using CV and DPV. Compared to the bare GCE, GO-GCE, and RGO-GCE, RGO/AuGCE showed higher peak currents and larger peak potential differences for the
detection of L-AA, DA and UA. Finally, the simultaneous detection of these three
different analytes with high sensitivity was achieved.

95

CHAPTER VI
ENHANCED SYNERGETIC ANTIBACTERIAL PROPERTIES OF REDUCE
GRAPHENE OXIDE/AG NANOCOMPOSITE
1. Introduction.
Since the emergence of drug-resistant bacterial strains, it is important to
develop new antibacterial agents that show better treatment efficacy in clinic.180, 181
Therefore, nanomaterials that possess excellent antibacterial activities provide a
promising direction for combating bacterial infections.182-184 Several nanomaterials
have been reported as antibacterial agents, such as silver nanoparticles (AgNPs),185-187
carbon nanotubes,188 graphene and graphene-based nanomaterials.189-195 Among these
antibacterial nanomaterials, the use of AgNPs has been deeply investigated and they
are undergoing the process for clinic application.196, 197
Graphene, the novel two-dimensional carbon nanomaterial discovered in
2004, has attracted tremendous attention from both chemists and biologist for its
excellent mechanical, optical, thermal and electronic properties.125-127,

146, 198, 199

Meanwhile, the great biocompatibility of the carbon nanomaterials makes graphene and
graphene-based nanomaterials excellent candidates for biomedical applications.200-202
Therefore, graphene-based nanomaterials have been used for the biosensing,203,

204

bioimaging,134, 205, 206 drug delivery145, 207-209 and construction of theranostic agents for
different diseases.210-212 Especially, the photothermal property of
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graphene can be used for targeting therapy with controlled laser irradiation.213 Because
of their large surface area and absorbing ability, graphene-based nanomaterials have
been widely used for cancer chemotherapy and photothermal therapy.207, 209, 214, 215
Recently, graphene-based materials have been used as efficient potential antibacterial
agents.190,

191

For example, Liu et al. investigated the antibacterial activity of four

different types of graphene-based materials and found thatgraphene oxide (GO) showed
the highest antibacterial activity, followed by reduced graphene oxide (RGO), graphite
and graphite oxide.191 By using the photothermal effect of RGO under near-infrared
(NIR) irradiation, Wu et al. developed magnetic nanoparticles modified RGO
composite to capture and kill bacteria through photothermal effect.189
To increase the antibacterial property, the AgNPs and graphene-based
nanomaterials were coupled together to form graphene/silver nanocomposite using
several different methods.192,

216-219

The resultant products showed enhanced

antibacterial activity due to their combination. Although these works showed strong
antibacterial ability of graphene/silver nanocomposites, to the best of our knowledge,
there has no been investigation of the synergetic effect of AgNPs and photothermal
effect of graphene on bacteria. By coupling these two antibacterial pathways, the
graphene/silver nanocomposite might be more efficient under NIR irradiation.
Therefore, in this work, we developed a facile, environmental friendly method to
fabricate RGO/Ag nanocomposite using glucose as a reducing agent. Using
Escherichia coli (E. coli) and Klebsiella pneumoniae (Kp) as the bacterial models, the
antibacterial efficiency of RGO/Ag nanocomposite was investigated under NIR
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irradiation. Furthermore, bacterial cell integrity and generation of ROS species with the
treatment of RGO/Ag nanocomposite and NIR irradiation were demonstrated to
uncover a possible mechanism of antibacterial activity of the RGO/Ag nanocomposite
besides photothermal effect.
2. Materials and Methods.
2.1. Materials and Instruments.
Graphene oxide was purchased from Cheap Tubes Inc., VT, which was
synthesized according to Hummer’s method from graphite flakes. Glucose (≥99.5%,
GC grade), silver nitrate (ACS reagent, ≥99.0 %) and ammonium hydroxide (ACS
reagent, 28.0 %) were purchased from Sigma Aldrich Inc. Phosphate buffered saline
tablets and fetal bovine serum were purchased from Fisher Scientific. Deionized (DI)
water (Millipore Milli-Q grade) with resistivity of 18.2 MΩ•cm was used in all
experiments. E. coli HB101 strain was obtained from American Tissue Culture
Collection (ATCC). Kp Xen-39 (ATCC 93A 5370), a bioluminescent pathogenic
bacterium strain expressing LUC bioluminescence was purchased from Caliper (Santa
Clara, CA).
A Hitachi SU8010 field emission scanning electron microscope was used to
take the SEM and STEM images of the RGO/Ag nanocomposite. Elemental analysis
for different RGO/metal nanocomposites was performed by an energy-dispersive X-ray
spectroscope (EDS) (Oxford, X-Max) installed in the Hitachi SU8010 SEM. X-ray
diffraction (XRD) profiles were obtained with a Bruker AXS D8 advanced powder Xray diffraction system using Cu Kα radiation. Fourier transform infrared (FTIR) spectra
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were obtained with a FT-IR spectrometer (Spectrum 400, PekinElmer) and UV-vis
absorption spectra were recorded with a Lambda 1050 UV/VIS/NIR spectrometer. The
photothermal effect study was performed by a BWF1 series fiber-coupled diode laser
system (750 mW at 808 nm) (B&W TEK Inc). Luminescence imaging was taken by
Caliper’s Xenogen IVIS optical imaging system (Caliper, PerkinElmer, Santa Clara,
CA).
2.2. Preparation of RGO/Ag Nanocomposite.
The RGO/Ag nanocomposites were prepared using a one-pot reaction. In brief,
5 mg homogeneous GO solution was mixed with 160.0 mg glucose for 30 min. An 80
µL aliquot of NH4OH (28.0 %) was added quickly to the solution and refluxed for 20
min. During this time, the color of the solution changed from brown-yellow to dark
black, indicating the formation of RGO from GO. Afterwards, 1.0 mL of 0.5 % AgNO3
solution was added drop wise and the mixture was refluxed for 15 min. Finally, the
cooled dispersed solution was filtered with 0.1 µm pore size membrane to separate the
unattached silver nanoparticles from RGO/Ag nanocomposite. Finally, the RGO/Ag
nanocomposite was redispersed into Milli-Q water with sonication for further use.
2.3. Antibacterial Activity Tests.
Bacteria were cultured in Lysogeny broth (LB) medium and shaken at 37 °C
overnight before use. The next day, the bacterial cells were harvested by centrifuge and
dispersed in PBS with an optical density at 600 nm (OD600) of 1.0. Then, the bacteria
were diluted to 108 CFU mL-1 with sterile PBS. The samples of GO, RGO, AgNPs, and
RGO/Ag nanocomposites in PBS were incubated with bacteria suspension,
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respectively. The samples were incubated at 37 °C for 2 hours followed by the
irradiation of 808 nm laser for another 10 min. Finally, 100 µL of the bacteria
suspension was added into 900 µL LB medium for the growth in a shaking incubator at
37 °C overnight. The concentration of bacteria was finally determined by measuring
OD600. Meanwhile, the plate count method was used to compare the killing effect of
RGO/Ag nanocomposite. Briefly, the bacteria suspension in LB medium treated with
RGO/Ag nanocomposites was plated on LB-agar plates, and incubated at 37 °C
overnight. The photographs were taken by commercial camera and the bioluminescence
images were taken by IVIS optical imaging system.
2.4. Cell Wall/Membrane Integrity Investigation.
Log phase E. coli (108 CFU mL-1) cells were dispersed in 200 µL PBS with or
without 15 µg/mL RGO/Ag nanocomposites. After growth for 2 h at 37 °C in the
incubator, the 808 nm laser irradiation was followed for another 10 min to carry out the
photothermal therapy. Then, the bacteria were stained with propidium iodide (PI, 1.25
µg/mL) and 4’-6-diamidino-2-phenylindole (DAPI, 12.5 µg/mL) for 15 min in the dark,
and then the cells were collected by centrifugation. The cells were then imaged using a
Nikon Eclipse 80i (upright) fluorescent microscope.
2.5. Cytotoxicity of RGO/Ag Nanocomposite to Mammalian Cells.
SW620 cells and MH-S cells were cultured in 1640 medium supplemented
with 10 % fetal bovine serum (FBS) at 37 °C overnight. Both cells were treated with
various concentrations of RGO/Ag nanocomposites at 37 °C for 24 h. Then, each well
was added 10.00 µL, 5 mg/mL MTT reagent. The cells were further incubated at 37 °C
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for 4 h until the purple color developed. 100.00 µL DMSO solution was added into each
well to stop reaction and dissolve the precipitant thoroughly. The absorbance of each
well was recorded at 570 nm to determine the cell proliferation rate.
2.6. Detection of Reactive Oxygen Species (ROS).
The possibility of ROS production was evaluated by the 2',7'dichlorodihydrofluorescein diacetate (H2DCFDA) assay. Briefly, a 50 µL aliquot of
bacteria (108/mL) was added with 100 µL, 0.04 mM H2DCFDA PBS solution and
incubated for 0.5 h. Then, 27 µL PBS or 0.1 mg/mL RGO/Ag nanocomposite (15
µg/mL final) were added and incubated for 1 h. Then, the irradiation (0.30 W/cm2) was
used to induce the photothermal treatment of E. coli for 10 min. After another 1 h
incubation at 37 °C, the fluorescence intensity (Ex: 485 -495 nm; Em: 515 – 525 nm)
was measured using microplate reader.
3. Results and Discussion.
3.1. Synthesis and Characterization of RGO/Ag Nanocomposite.
Our goal was to develop a synergetic nanocomposite as an efficient
antibacterial agent. Based on the antibacterial properties of silver nanoparticles and the
photothermal effect of RGO, our hypothesis was that the combination of RGO and
silver nanoparticles would generate the highly efficient antibacterial agent. As reported
in our previous work, an environmentally friendly and facile method was used to
prepare the RGO/Ag nanocomposite using glucose as the reducing agent and the
resulted gluconic acid as the stabilizer. The silver nanoparticles were anchored on the
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defects of the GO sheets. At the same time, the GO was reduced to form RGO with
glucose.
We characterized the formation of the RGO/Ag nanocomposite using several
methods. As shown in Figure 48 A and B, The STEM and SEM images showed that
silver nanoparticles were deposited on the surface of RGO sheet. From measuring more
than fifty silver nanoparticles, the average diameter of silver nanoparticles on RGO
sheet was determined to be 53.4 ± 0.9 nm. Then, the energy dispersive X-ray
spectroscopy (EDS) was used to analyze the content of the nanocomposites. As shown
in Figure 48C, the nanocomposite contained elements of carbon and oxygen, which
indicated the presence of RGO, and silver for silver nanoparticles. The copper peak was
associated with the TEM sample grid.

Figure 48. STEM (A) and SEM (B), and EDS (C) of RGO/Ag nanocomposite.
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Figure 49. Absorption spectra of GO, AgNPs, RGO, RGO/Ag nanocomposite.
We further confirmed the formation of RGO/Ag nanocomposites using
spectroscopic strategies. As shown in Figure 49, compared with the characteristic
absorption peak of GO at 230 nm and pure silver nanoparticles at 400 nm, the RGO
displayed a peak red shift to 260 nm. For RGO/Ag nanocoposites, the 260 nm
absorption peak indicated the successful reduction of GO to RGO, and the 400 nm peak
suggested that the silver nanoparticles were successfully deposited on the RGO sheets.
During the reduction process, glucose was oxided to gluconic acid, which may act as a
stabilizer on the surface of RGO to keep the nanocomposites from aggregating. As
shown in the inset of Figure 49, even one year after the synthesis, the RGO/Ag
nanocomposites exhibited excellent water-dispersibility.
FTIR and XRD were used to further characterize the RGO/Ag
nanocomposites. As shown in Figure 50A, compared with the curve of GO, the C=O
stretching absorption band at 1725 cm-1 was dramatically decreased in RGO and
RGO/Ag nanocomposites. Meanwhile, the C=C stretching peak at 1620 cm-1 increased.
These changes indicated that the GO was successfully reduced during the synthesis
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process. As shown in Figure 50B, the XRD pattern of RGO/Ag showed the peaks at
38.1° 42.2°, 64.5°and 77.5°, which were the characteristic peaks of silver pattern.

Figure 50. (A) FTIR of GO, RGO and RGO/Ag nanocomposite; (B) XRD pattern of
RGO/Ag nanocomposite.
3.2. Photothermal Effect of RGO/Ag Nanocomposite.
Due to the increased absorption in the NIR region of RGO/Ag nanocomposite,
the laser irradiation at 808 nm at a power density of 0.30 W/cm2 was used to study the
photothermal effect of RGO/Ag nanocomposite in solution. Four controls were used
including water, GO solution, AgNPs solution and RGO solution. As shown in Figure
51, water, GO and AgNPs had virtually no change in temperature, whereas the RGO
and RGO/Ag solution showed a rapid increase in temperature upon exposure to the
laser in 10 min, and reached a plateau after 20 min of irradiation. With the same
concentration of RGO (0.02 mg/mL), RGO/Ag nanocomposite showed a slightly higher
temperature change than that of RGO solution. In addition, a larger temperature
increase could be obtained by increasing the concentration of RGO/Ag nanocomposite.
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These results demonstrated that the RGO/Ag nanocomposite can act as an efficient
photothermal agent.

Figure 51. Temperature evolution profile of H2O, AgNPs, GO, RGO and RGO/Ag
nanocomposite upon NIR (808 nm, 0.3 W/cm2) irradiation.
3.3. Synergistically Enhanced Antibacterial Activity of RGO/Ag Nanocomposite.
In the above results, the RGO/Ag nanocomposite had efficient photothermal
effect with the irradiation of 808 nm laser. Combined with the efficient antibacterial
activity of silver nanoparticles, the RGO/Ag nanocomposite was expected to possess to
an efficient antibacterial effect. Therefore, the synergistic antibacterial activity of
RGO/Ag nanocomposite was investigated using E. coli and Kp. As shown in Figure
52A, 15 µg/mL AgNPs decreased the viabilities of E. coli cells to about 85 %, which
indicated the intrinsic antibacterial activity of AgNPs. In the other two control groups,
including GO and RGO treatment, the E. coli cell viabilities did not dramatically
decrease without irradiation, which illustrated that the GO and RGO did not have
significant impact on bacteria without the irradiation. However, when the samples were
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Figure 52. (A) Bacterial cell viability of E. coli after treatments with 15 µg/mL AgNPs,
15 µg/mL pure GO, 15 µg/mL pure RGO and 15 µg/mL RGO/Ag nanocomposite with
and without NIR irradiation (808 nm, 0.3 W/cm2). (B) Bacterial cell viability of Kp
after treatments with 30µg/mL AgNPs, 30 µg/mL pure GO, 30 µg/mL pure RGO and
30 µg/mL RGO/Ag nanocomposite with and without NIR irradiation (808 nm, 0.3
W/cm2).
treated the NIR irradiation, the photothermal effect of RGO decreased the cell viability
of E. coli to about 84 %. In contrast, the groups treated with AgNPs and GO did not
cause cell viability decrease with the NIR irradiation due to their low photothermal
effect (Figure 51). However, in the group treated with RGO/Ag, the cell viability of E.
coli decreased to about 35 % without irradiation, and the cell viability of E. coli was
1.8 % after 10 min irradiation. The extremely low cell viability of E. coli treated
RGO/Ag was carried out by the combination of the intrinsic antibacterial activity of
AgNPs and photothermal effect of RGO at low concentration. For the treatment of
another bacterial, Kp, it was showed the similar results with that of E. coli. As shown
in Figure 52B, with the same concentration at 30 µg/mL, only RGO/Ag nanocomposite
killed the Kp cell to about 2.4 % after the irradiation. The synergistically enhanced
antibacterial activity of RGO/Ag nanocomposite with NIR irradiation was clearly
demonstrated.
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Figure 53. (A) Bacterial cell viability of E. coli after treatments with different
concentrations of RGO/Ag nanocomposite with and without NIR irradiation (808 nm,
0.3 W/cm2). (B) Bacterial cell viability of Kp after treatments with different
concentrations of RGO/Ag nanocomposite with and without NIR irradiation (808 nm,
0.3 W/cm2).
Then, we investigated the effect of the concentration of RGO/Ag
nanocomposite on the antibacterial activity. As shown in Figure 53, with the increase
of the concentration of RGO/Ag nanocomposite, the cell viability of E.coli and Kp both
decreased no matter the irradiation was conducted. However, with the treatment of
irradiation, the cell viability decreased faster. The IC50 was estimated at about 12 and 5
µg/mL for E. coli without and with irradiation, respectively. Similarly, the IC50 for the
treatment of Kp was estimated at about 35 and 15 µg/mL without and with irradiation,
respectively. Apparently, RGO/Ag nanocomposite exhibited a higher antibacterial
activity against E. coli than Kp, indicating that the Kp is a hard bacterial to be removed
from the infection. Furthermore, CFU counting method was used to investigate the
number of viable bacterial cells after the treatment of RGO/Ag nanocomposite and
irradiation. As shown in Figure 54, for both E. coli and Kp cells, nearly no bacterial
colony on the LB-agar plate was formed when RGO/Ag nanocomposite and irradiation
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were both treated. The groups treated with RGO/Ag nanocomposite only also decreased
the colony counts, but not as low as that with irradiation at the same time. In contrast,
the irradiation only has nearly no impact on the colony number.

Figure 54. (A) Representing photographs of E. coli colonies treated with RGO/Ag
nanocomposite formed on LB-agar plates. (a) control; (b) control with laser irradiation;
(c) 15 µg/mL RGO/Ag nanocomposite; (d) 15 µg/mL RGO/Ag nanocomposite with
laser irradiation. The laser irradiation was conducted under 808 nm with 0.3 W/cm2.
Representing photographs (B) and luminescence images (C) of Kp colonies treated with
RGO/Ag nanocomposite formed on LB-agar plates. (a) control; (b) control with laser
irradiation; (c) 30 µg/mL RGO/Ag nanocomposite; (d) 30 µg/mL RGO/Ag
nanocomposite with laser irradiation. The laser irradiation was conducted under 808
nm with 0.3 W/cm2.
3.4. RGO/Ag Nanocomposite Caused Cell Integrity Disruption and ROS Generation
with the Irradiation.
To further explore the antibacterial mechanism of RGO/Ag with irradiation,
two aspects, including cell integrity and ROS generation, were investigated using E.
coli as a model. Two fluorescent nucleic acid dyes, DAPI and PI, were used to stain
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Figure 55. Fluorescence images of live and dead E. coli cells after incubation with 15
µg/mL of RGO/Ag nanocomposites for 2h: (A) E. coli with laser treatment; (B) E. coli
with RGO/Ag nanocomposites; (C) E. coli treated with RGO/Ag nanocomposite and
laser irradiation. Blue fluorescence shows bacterial quasi nuclear stained with DAPI,
while red fluorescence shows dead bacteria stained with PI. The scale bar is 20 µm.
the E.coli cells. DAPI labels all the cells, and PI can only stain the cells whose cell
membranes are damages and lost the integrity. As shown in Figure 55A, the E. coli cells
with only irradiation treatment had few dead cells. In the group treated with RGO/Ag
nanocomposite only, a large number of cells were stained by PI, but a part of
accumulated cells were still stained by DAPI only (white arrow in Figure 55B).
However, in the group that was treated with RGO/Ag nanocomposite and irradiation,
most of the E. coli cells were stained by both DAPI and PI, indicating disruption of cell
walls and cell membranes. Therefore, the exposure to RGO/Ag nanocomposite
with/without irradiation leads to the disruption of cell integrity. The damaged
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membranes were more significant when the photothermal effect of RGO/Ag
nanocomposite was introduced.

Figure 56. ROS generation of E. coli by the treatment of RGO/Ag nanocomposite (15
µg/mL) and 10 NIR irradiation.
Furthermore, by using H2-DCF assay, we investigated the generation of ROS
species when the RGO/Ag nanocomposite was used to treat E. coli with irradiation. As
shown in Figure 56, compared with the control group, which the E. coli cells were
treated with irradiation only, the fluorescent intensity significantly increased when the
RGO/Ag nanocomposite was used to treat the bacteria. Moreover, when the irradiation
was introduced with RGO/Ag nanocomposite, the fluorescent intentisy of H2-DCF was
enhanced than that without irradiation. These results indicated that the treatment of
RGO/Ag nanocomposite without/with irradiation both generated RGO species in the
cells. Even though it was unclear that the generation of ROS species is direct or indirect
production, the ROS species should be responsible for the antibacterial activity of
RGO/Ag nanocomposite. If the ROS species was generated directly from the RGO/Ag
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nanocomposite with the irradiation, the RGO/Ag nanocomposite would be potential
photodynamic therapeutic agent both bacterial infection and other diseases like cancer.

Figure 57. Relative cell viability of SW620 and MH-S after culturing with different
concentrations of RGO/Ag nanocomposite varying from 0, 5, 10, 20, 30 to 40 µg/mL
for 24 h at 37 °C. After the addition of MTT reagent and 4 h incubation at 37 °C, stop
solution was added and followed by overnight incubation. The absorbance of each
sample was recorded at 570 nm to determine the cell proliferation rate.
3.5. Cytotoxicity Investigation.
To investigate the cytotoxicity of RGO/Ag nanocomposite toward mammalian
cells, two cell lines, including a macrophage cell line (MH-S) and a colon cancer cell
line (SW620), were used. The cell viabilities of these cell lines treated with different
concentrations of RGO/Ag nanocomposite for 24 h were investigated using MTT assay.
As shown in Figure 57, after treatment of RGO/Ag nanocomposite for 24 h at 20
µg/mL, both MH-S cells and SW620 cells still have more than 75 % live cells.
However, more than 98 % of E. coli and Kp were killed within 2 h followed by 10 min
irradiation at the same concentration of 20 µg/mL. The viabilities of both cells retained
above 60 % at higher concentrations, indicating that RGO/Ag nanocomposite may be a
low cytotoxic, efficient antibacterial agent with irradiation.
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4.

Conclusions.

In conclusion, a facile and environmentally friendly method was introduced to
prepare RGO/Ag nanocomposite using glucose as a reducing agent. With intrinsic
antibacterial activity of AgNPs and photothermal effect of RGO, the RGO/Ag
nanocomposite was used to kill bacterial with high efficiency. The MIC of RGO/Ag
nanocomposite coupled with irradiation against E. coli and Kp were 5 µg/mL and 10
µg/mL, respectively. The results demonstrated the the RGO/Ag nanocomposite showed
better performance of bactericidal effect against E. coli than that toward Kp. Besides
the photothermal effect of RGO/Ag nanocomposite, cell disruption and generation of
ROS species might be other reasons for the high efficient antibacterial activity.
Moreover, the RGO/Ag nanocomposite showed low cytotoxicity at the low
concentrations which are sufficient for killing bacteria. Overall, the results in this work
combined the intrinsic antibacterial activity of AgNPs and photothermal effect of RGO
to construct an enhanced synergetic antibacterial agent that has potential to be used in
industry and clinic.
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CHAPTER VII
LONG RANGE FLUORESCENCE QUENCHING OF GRAPHENE OXIDE WITH
RIGID SILICA SHELL AS TUNABLE SPACER
1. Introduction.
Graphene, the novel two-dimensional carbon nanomaterial, has attracted
tremendous research interest due to its excellent optical, electrical, thermal, and large
surface properties.126, 202, 220 Using the modified Hummer’s method, graphene oxide
(GO) can be easily produced and scaled up.221 GO possesses unique optical properties
compared to the pristine graphene, due to the destruction of the sp2 carbon structure.
The band-zero graphene generates adjustable band-gaps in GO, making them suitable
for fluorescence imaging and construction of optical devices.222-224 In addition, oxygencontaing groups, such as carboxyl and hydroxyl groups provide the high aqueous
solubility and active sites for further modification.199 Furthermore, it has been reported
that GO is also excellent quencher for fluorophores and quantum dots.100, 225-229 It has
been widely used for the fabrication of fluorescent biosensors based on their quenching
ability.127, 230, 231 Through π-π stacking, single-stranded DNA (ssDNA) modified with
fluorophore can be absorbed onto the surface of GO, leading to the fluorescence
quenching. When the ssDNA forms double-stranded DNA (dsDNA) or well-folded
structures, the distance between the fluorophore and GO surface will be
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increased to restore fluorescence emission.203,

232

This strategy has been used for

sensitive detection of nucleic acids, proteins, small molecules and metal ions.204, 233-237
Therefore, sophisticated design of biosensors and bioimaging agents using GO would
be dramatically improved by the fundamental investigation of the quenching ability of
GO to fluorophores. However, the quenching mechanism of GO has been rarely
reported.
Theoretically, the energy transfer rate from fluorophore to GO was dependent
on the distance between the donor and acceptor followed a d-4 dependency.238 In
contrast to the traditional FRET process with d-6 dependency,239 the quenching ability
of GO should be better than traditional quencher. Recently, Huang et al.240 and Piao et
al.241 investigated the quenching ability of GO to fluorophores of FAM and Cy3.5,
respectively. DNA strands were used to separate the fluorophores and GO in these two
works with variations in the length of DNA strands and the formation of dsDNA
strands. The Froster distance (d0), which was defined as the distance for 50 %
quenching, was found as 7.5 ± 0.6 nm in Huang’s work.240 However, in these two
works, DNA strands were chosen for the distance spacer, which led to a serious
limitation. Due to the flexibility of DNA strands, even in the dsDNA format, they may
have leaned at an angle to the surface of GO. The distance calculation through counting
bases in DNA might cause the miscalculation because of the assumption that these
DNA strands were perpendicular to the surface of GO. For instance, Piao et al. reported
the quenching efficiency of GO increased after 13 bases, which implied the bended
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structure of dsDNA. Therefore, a better model is necessary for more precious
investigation of the quenching ability of GO to fluorophores.
Herein, we demonstrated that a rigid spacer can be used to better understand
the quenching ability of GO. As we reported before, silica is an inert rigid structure that
can be used to separate the fluorophores and gold nanoparticles in the investigation of
the metal-enhanced fluorescence.242, 243 Therefore, by coating different thicknesses of
silica spacers on the fluorophores, the quenching ability of GO to fluorophores can be
delicately measured in this model.
2. Methods and Materials.
2.1. Materials and Instruments.
Single Layer Graphene oxide (GO) was purchased from Cheap Tubes Inc.,
VT.

Tris(bipyridine)ruthenium(II)

chloride

(Rubpy),

1-Hexanol

(99+

%),

Tetraethylorthosilicate (TEOS, 98%), 3-ami-nopropyltriethoxysilane (APTES, 95%)
were purchased from Sigma-Aldrich. Ammonium hydroxide (28.0% − 30.0%), cyclohexane (HPLC grade), and ethanol were obtained from Fisher Scientific Co.
Carboxytetramethylrhodamine-succinimidyl ester (TAMRA-SE) was purchased from
Molecular Probes. Deionized (DI) water (Millipore Milli-Q grade) with resistivity of
18.2 MΩ•cm was used in all experiments.
A Hitachi SU8010 field emission scanning electron microscope was used to
take the SEM images of the composite of silica nanoparticles and graphene oxide. A
Hitachi 7500 transmission electron microscope (TEM) was used to take the images and
measure the diameters of silica nanoparticles. UV-vis absorption spectra were recorded
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with a Lambda 1050 UV/VIS/NIR spectrometer. A Jobin Yvon Horiba Fluorolog
spectrofluorometer was employed for fluorescence intensity measurements. Zeta
potential was detected using a Zetasizer (Marlwen, model of Nano-ZS). An Eppendorf
5810 R centrifuge was used to wash silica nanoparticles.
2.2. Synthesis of SiNPs@TAMRA.
First, the SiNPs cores were synthesized using the reverse microemulsion
method. Briefly, 7.5 mL cyclohexane, 1.6 mL 1-hexanol, 1.8 mL Triton X-100, and
0.48 mL H2O were mixed with vigorous stirring. After stirring for 15 min, 100 µL
NH4OH was added followed by the addition of 400 µL TEOS to initiate the formation
of silica nanoparticles. After 30 min, 80 µL APTES was injected to co-polymerize with
the TEOS to provide amino groups on the surface of SiNPs. The reaction was allowed
to proceed overnight and was followed up with ethanol and water washes. Finally, the
formed SiNPs with amino groups were dispersed in 20 mL water with concentration of
4 mg/mL. For conjugating TAMRA onto the surface of SiNPs, 20 mL of 4 mg/mL
SiNPs was mixed with 0.5 mL TAMRA-SE and allowed to conjugate overnight. The
SiNPs@TAMRA was then washed with water three times to obtain

4 mg/mL

SiNPs@TAMRA dispersed in water.
2.3. Formation of SiNPs@TAMRA@Si-NH2.
To coat a layer of silica on the surface of SiNPs@TAMRA with different
thicknesses, the modified Stӧber method was used. Briefly, 10 mL EtOH, 0.2 mL of 4
mg/mL SiNPs@TAMRA prepared in the previous step, 0.18 mL water, 0.5 mL
NH4OH, and different amounts of TEOS, ranging from 0.3, 0.6, 1.0, 2.0, 3.0, 4.0, 5.0,
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7.5, and 10.0 µL, were stirred together for 2 hours. Then 0.15, 0.30, 0.50, 1.00, 1.50,
2.00, 2.50, 3.25, and 7.5 µL APTES was added into the mixture to modify amino groups
on the surface of silica shell. After 0.5 hour, EtOH and water were used to wash the
SiNPs@TAMRA@Si-NH2 via centrifuge.
2.4. Formation of SiNPs@Rubpy@Si-NH2.
First, the SiNPs cores were synthesized using the reverse microemulsion
method as previously mentioned. Then, a silica coating process coupled with Rubpy
doping was carried out by the modified Stӧber method. Briefly, 10 mL EtOH, 2 mL of
4 mg/mL SiNPs prepared in the previous step, 0.5 mL NH4OH, 1 mL 0.1 M Rupby
solution and 20 µL TEOS were mixed to start the doping of Rubpy into the silica shell.
Furthermore, to adjust the distance between the Rubpy and GO, different thicknesses
of silica shell were generated by a similar process to section 2.3 of altering the amount
of the TEOS and APTES during the coating process.
2.5. Fluorescence Quenching Investigation.
The experiment was carried out on a Jobin Yvon Horiba Fluorolog
spectrofluorometer. Briefly, 100 µL, SiNPs@TAMRA@Si-NH2 (equi 0.1 nM
TAMRA) solution was placed in a quartz cuvette for the fluorescence measurement.
The excitation wavelength was set at 540 nm. The fluorescence spectrum was recorded
from 560 nm to 650 nm. The slits for excitation and emission were set at 5 nm. After
the recording of the origin fluorescence spectrum of SiNPs@TAMRA@Si-NH2, 1 µL
of 5 mg/mL GO was added into the solution and mixed using pipette. The fluorescence
spectrum was measured 2 min later to investigate the quenching ability.
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2.6. Fluorescence Lifetime Measurement.
100 µL of SiNPs@TAMRA@Si-NH2 (equi 0.1 nM TAMRA) solution was
loaded into a quartz cuvette for lifetime measurement. The fluorescence lifetime was
collected using a Jobin Yvon Horiba Fluorolog spectrofluorometer equipped with LED
laser. The LED laser light source at 494 nm was used for the excitation. The emission
data was collected at 575 nm with an 8 nm slit.
3. Results and Discussion.
3.1. Design of SiNPs@TAMRA@Si-NH2 Wrapped with GO.
The fluorescence quenching ability of GO has been widely used for the
fabrication of sensitive biosensors and bioimaging agents. However, the fundamental
investigation of GO quenching ability was poorly elucidated by two recently works
which used flexible DNA strands as the spacer. Herein, we designed a rigid spacer
between GO and fluorophores, which would diminish the effect of inaccurate distance
calculation with the DNA strands spacer. In our previous study, rigid silica shell was
used to investigate the fluorescence enhancement effect of gold nanoparticles by
adjusting the distance between gold nanoparticles and fluorophores. Therefore, we used
the silica shell as a spacer between fluorophores and GO in this work to investigate the
quenching ability of GO. Silica shell is used because of its inert nature, which does not
change the interaction between the fluorophores and the investigated nanomaterials. As
shown in Scheme 4, amino group modified silica nanoparticles (SiNPs) was
synthesized firstly using the reverse micro-emulsion method. Then, a fluorophore,
named TAMRA-SE was conjugated to the SiNPs through the interaction of amino
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groups and succinimidyl ester group. Therefore, SiNPs@TAMRA was therefore
formed without any silica shell coating. In order to adjust the distance between TAMRA
and GO in the following steps, a silica shell was coated using the Stӧber method. In this
coating process, APTES was added to co-polymerization with TEOS to form amino
groups on the surface of final nanopartilces (SiNPs@TAMRA@Si-NH2). The thickness
(d) of the silica shell was controlled by the amount of TEOS and APTES. With addition
of GO to the solution of SiNPs@TAMRA@Si-NH2, GO would wrap the positively
charged SiNPs@TAMRA@Si-NH2 through electrostatic interaction and thereby to
quench the fluorescence of TAMRA with distance dependence.

Scheme 4. Schematic of synthesis of SiNPs@TAMRA@Si-NH2 nanocomposite and
investigation of fluorescence quenching ability of GO to TAMRA with distance (d)
dependent.
3.2. Characterization of GO.
GO was purchased from the commercial company and dispersed into water
through 2 hours ultrasonic treatment to obtain the stable solution (5 mg/mL). The SEM
and STEM in Figure 58A and 58B show that the GO sheet size is in the micrometers
range. As shown in Figure 58A, the wrinkles of GO were clearly observed from the
SEM image. The large size and flexibility of GO sheet ensured the ability of the GO to
wrap the silica nanoparticles through electrostatic binding force. Figure 58C
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demonstrated the UV-vis absorption spectrum of GO solution. The strong peak at ca.
230 nm was due to the π-plasmon of the sp2 carbon structure and the shoulder around
300 nm was ascribed to the n to π* transitions.
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Figure 58. SEM (A), STEM (B) images and absorption spectrum (C) of GO.
3.3. Fluorescence Quenching of GO to SiNPs@TAMRA@Si-NH2.
Graphene oxide was reported to quench several fluorescent dyes, from visible
to near-infrared region. Therefore, it is useful for the fabrication of fluorescent
biosensors. We initially investigated the quenching ability of GO to the TAMRA
conjugated on the surface of amino groups modified silica nanoparticles
(SiNPs@TAMRA). As shown in Figure 59A, the shape of absorption spectra of
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SiNPs@TAMRA before (curve a) and after (curve b) incubation with GO are similar
to each other. The only difference was the intensity of the two curves, which resulted
from the addition of GO. However, after the addition of GO to SiNPs@TAMRA, the
fluorescence intensity of TAMRA was almost quenched (~ 93.4 %) (Figure 59B). To
investigate the mechanism of the fluorescence quenching property of GO, the liftetimes
of SiNPs@TAMRA before and after addition of GO were measured. As shown in
Figure 59C, the lifetime of SiNPs@TAMRA decreased from 2.12 ± 0.02 ns to 0.20 ±
0.02 ns. The quenching efficiency was found to be 90.6% calculated from the lifetime
change using 𝑄 = 1 − 𝜏/𝜏0 , where τ0 and τ are the lifetimes of SiNPs@TAMRA
without and with addition of GO, respectively. The close value of quenching
efficiencies calculated from the total fluorescence intensity and lifetimes indicated that
the main quenching mechanism of GO to TAMRA was dynamic quenching.
Meanwhile, the similar absorption spectra pattern also supported this point. Due to the
electrostatic interaction between the positive charged SiNPs@TAMRA and negative
charged GO, GO should have adsorbed onto the surface of SiNPs@TAMRA once they
were mixed together. Therefore, TEM and SEM images were used to demonstrate the
interaction between GO and SiNPs@TAMRA. As shown in Figure 59D, the wrinkles
on the edges of SiNPs@TAMRA (white arrow) clearly indicated the totally coverage
of the GO on the SiNPs@TAMRA. The distance between TAMRA and GO was
estimated as 0 nm because the TAMRA was covalently conjugated onto the surface
SiNPs and the GO was compactly wrapped on the surface of SiNPs through amino
groups.
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Figure 59. Absorption (A) fluorescence (B) spectra of SiNPs@TAMRA without (a) and
with (b) GO. λex = 540 nm. (C) Lifetime measurements of SiNPs@TAMRA without
(b) and with (c) GO. Curve a is the reference. 492 nm LED laser was used in the lifetime
measurement. (D) SEM image of SiNPs@TAMRA with GO. Inset is TEM image of
SiNPs@TAMRA with GO, bar is 200 nm. The white arrows indicate the wrinkle of GO
wrapped on the surface of nanoparticles.
To find the maximum quenching efficiency of GO with SiNPs@TAMRA, we
measured the fluorescence of SiNPs@TAMRA with different concentrations of GO.
As shown in Figure 60, the fluorescence intensity of SiNPs@TAMRA decreased with
the increase of the concentration of GO. The quenching efficiency reached a plateau
after 10 µg/mL. Therefore, we chose 50 µg/mL GO for the following experiment to
ensure that the quenching efficiency was only related to the distance between TAMRA
and GO but not to the concentration of GO.
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Figure 60. Fluorescence quenching of SiNPs@TAMRA with different concentration of
GO. (A) Fluorescence spectra of SiNPs@TAMRA with different concentrations of GO.
From top to bottom: 0, 1.0, 2.0, 3.0, 4.0, 5.0, 7.5, 10.0 and 20.0 µg/mL. (B) Quenching
efficiency GO to SiNPs@TAMRA with different concentrations. λex = 540 nm; λem
= 575 nm.
Afterward, the distance between TAMRA and GO was adjusted by the silica
shell thickness. As shown in Figure 61, the different thicknesses of silica shell were
coated on the surface of SiNPs@TAMRA using the Stӧber method through changing
the amount of TESO and APTES. The sizes of the resulting nanoparticles were
measured by TEM. The distance between TAMRA and GO was calculated by
subtracting the radius of the SiNPs@TAMRA from SiNPs@TAMRA@Si-NH2. With
the increase in the amount of TEOS, the distances were calculated as 0.3, 1.2, 6.5, 14.7,
and 34.5 nm. Meanwhile, the amino group modified on the outside surface of the silica
nanoparticles ensured the positive charge that can be adsorbed with GO. After
introduction of 50 µg/mL GO, the fluorescence intensity of TAMRA in silica
nanoparticles was quenched. With the increase of the thickness of the silica shell, the
quenching efficiency decreased. As shown in Figure 62, the distance between TAMRA
and GO was larger than 30 nm and the quenching efficiency of GO was still around 30
%, which indicated the long-distance quenching ability of GO.
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Figure 61. TEM images of SiNPs@TAMRA@Si-NH2 with different thickness of 0, 0.3,
1.2, 6.5, 14.7, and 34.5 nm (A to F).
According to the theoretical calculations of the quenching effect of graphene,
𝑑

it showed a relationship of 𝑄 = 1/[1 + (𝑑0)4 ], where d is the distance between
graphene fluorophore and d0 was the characteristic distance. The d0 is reported different
from each other regarding the various systems, ranging from ~ 5 to 8 nm.240, 244 By
measuring the quenching efficiency of our TAMRA-GO system, the GO quenched the
~ 50% of TAMRA fluorescence when the silica thickness was ~ 6.54 nm (Figure 62).
This concluded that the d0 for TAMRA-GO system was about 6.54 nm.
The quenching efficiency calculated from the steady-state fluorescence
reflected the total quenching, including static and dynamic components. We then
measured the lifetime of TAMRA when GO was presented to quench the fluorescence.
The quenching efficiency was calculated by 𝑄 = 1 − 𝜏/𝜏0 , where τ0 is the lifetime of
TAMRA in the absence of GO, and τ is the lifetime of TAMRA in the presence of GO.
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As shown in Figure 62B, the quenching efficiency calculated from lifetime was also
plotted with the thickness of silica shell. As expected, it decreased with the increase of
the thickness of silica shell. The quenching efficiencies obtained from these two
methods were similar with each other, indicating that the main quenching mechanism
was dynamic quenching.

Figure 62. (A) Fluorescence spectra of SiNPs@TAMRA@Si-NH2 with GO. The
distances between TAMRA and GO were 0, 0.3, 1.2, 6.5, 14.7, 34.5 nm (curve a to f).
Curve g was SiNPs@TAMRA without addition of GO. (B) Quenching efficiency of
the doped TAMRA as a function of the distance. The quenching efficiency was
calculated based on average fluorescence lifetime (squares) and from steady-state
fluorescence intensity (circles). The concentrations of nanoparticles were equi ca 0.1
nM of TAMRA. λex = 540 nm; λem = 575 nm.
3.4. Fluorescence Quenching of GO to SiNPs@Rubpy@Si-NH2.
To investigate the universal quenching ability of GO, we changed the
fluorophore from TAMRA to Rubpy, which is another useful dye with the emission of
600 nm. Instead of the covalent conjugation between amino groups on silica
nanoparticles and TAMRA, the Rubpy was doped into a thin layer of
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Figure 63. TEM images of SiNPs (A), SiNPs@Rubpy (B), and SiNPs@Rubpy@SiNH2 with different thicknesses of 2.4, 3.0, 3.7, 4.8, 7.8, 10.1, and 15.6 nm (C to I).
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Figure 64. Fluorescence quenching of SiNPs@Rubpy with different concentrations of
GO. (A) Fluorescence spectra of SiNPs@ RuBpy with different concentrations of GO.
From top to bottom: 0, 10, 20, 30, 40 and 50 µg/mL. (B) Quenching efficiency GO to
SiNPs@ RuBpy@Si-NH2 with different concentrations. λex = 460 nm; λem = 600 nm.
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silica shell (SiNPs@Rubpy). Then, another layer of pure silica shell was coated on the
surface of Rubpy-doped silica nanoparticles and followed with the modification of
amino groups (SiNPs@Rubpy@Si-NH2). The distance between Rubpy and GO was
calculated by subtracting the radius of SiNPs@Rubpy@Si-NH2 by the radius of
SiNPs@Rubpy. The distances were obtained from 2.4, 3.0, 3.7, 4.8, 7.8, 10.1, to 15.6
nm (Figure 63). We first investigated the quenching efficiency of GO to SiNPs@Rubpy
with different concentrations (Figure 64). As the concentration of GO increased, the
fluorescence intensity of Rubpy at 600 nm decreased and reached a plateau when the
concentration of GO was 50 µg/mL. Therefore, we chose 50 µg/mL of GO for the
following quenching efficiency investigation. As shown in Figure 65A, by increasing
the distance between Rubpy and GO, the fluorescence intensity of Rubpy recovered
from the quenching state. The quenching efficiency calculated from the steady-state
fluorescence intensity was plot with the distance (Figure 65B). It followed the similar
trends as that of the TAMRA nanoparticles. The characteristic distance was evaluated
around 5.0 nm smaller than that of the TAMRA, when the quenching efficiency was 50
%. The lifetime of Rubpy was dramatically decreased when it was doped into the thin
layer of silica shell, which was out of our detection limit of the instrument. Therefore,
the dynamic quenching mode was not investigated. Overall, the GO can quench the
fluorescence of Rubpy with a distance-dependent manner.
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Figure 65. (A) Fluorescence spectra of SiNPs@Rubpy (a) and SiNPs@Rubpy@Si-NH2
with 50 µg/mL GO. The distances between Rubpy and GO were separated by 2.4, 3.0,
3.7, 4.8, 7.8, 10.1, and 15.6 nm silica space (curve b to h). (B) Quenching efficiency of
the doped Rubpy as a function of the distance. The concentrations of nanoparticles were
equi ca 0.1 nM of Rubpy. λex = 460 nm; λem = 600 nm.
4. Conclusions.
In conclusion, we have demonstrated the quenching ability of GO with two
different fluorophores, TAMRA and Rubpy. The distance between the fluorophore and
GO was adjusted by a rigid silica layer, which is more accurate than soft DNA strands.
The quenching efficiency of GO to these two fluorophores followed a distancedependence with characteristic distance of 6.54 and 5.0 nm, respectively. By comparing
the steady-state total quenching efficiency and dynamic quenching efficiency of GO to
TAMRA, we found that the main quenching mechanism was dynamic quenching.
Moreover, the quenching range of GO with these fluorophores was much greater than
the traditional FRET distance (10 nm). By exposing the long-range quenching
properties of GO to fluorophores, we further promoted applications of GO in analytical
and biomedical probes design as a carrier and fluorescence quencher.
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CHAPTER VIII
GRAPHENE OXIDE KILLS KLEBSIELLA PNEUMONIA BACTERIUM IN
MACROPHAGES AND IN MICE
1. Introduction
Due to the excessive use of antibiotics in the last century, super bacteria which
are resistant to those antibiotics can cause serious problems in the hospital.245 For
instance, Klebsiella pneumoniae (Kp), which is a clinical pneumococcus, continuously
acquires carbapenem-resistant properties due to the wide usage of carbon penicillin
antibiotics in hospitals.246,

247

Further, Kp can easily infect patients who have pre-

conditions, including cystic fibrosis, asthma and emphysema.247 Therefore, it is urgent
to develop effective new antibiotics and/or therapeutic agents to fight against the
multiple-drug-resistant (MDR) bacteria.248 Recently, a variety of antibacterial
nanomaterials have attracted attention.249-251 The antibacterial mechanisms of
nanomaterials may be different from those of conventional antibiotics and can be used
as auxiliary or alternative strategy to facilitate therapy of MDR bacterial infection.252,
253

For example, silver nanoparticles have been reported to efficiently kill bacteria and

have already entered the market.253-255 More recently, graphene, a 2-dimensional carbon
nanomaterial, has shown great potential as an antibacterial agent.256-258
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Graphene has been tested for several fields owing to its large surface area as
well as excellent mechanical, electronic, and optical properties.199, 220 In biomedical
fields, graphene-derivatives, including graphene oxide (GO), reduced graphene oxide
(rGO), graphene quantum dots (GQDs) and graphene-based nanocomposites, have
been widely examined for applicability in biosensors,233, 259 bioimaging,145, 205, 260 drug
delivery,209, 215 and photothermal therapy.146, 201, 261 Meanwhile, graphene-derivatives
can be used for killing bacteria. For example, graphene oxide and reduced graphene
oxide showed toxicity to both Gram-positive and Gram-negative bacteria.256, 257 The
contact of graphene derivatives with cell membrane caused direct damage to bacteria
because of their extremely sharp edges.

Liu et al. compared the antibacterial

properties of four different carbon materials, including graphite, graphite oxide, GO
and rGO.191 They found that GO possessed the highest antibacterial activity while
graphite oxide exhibited the lowest antibacterial activity. Meanwhile, a three-step
antimicrobial mechanism was proposed for graphene-based materials, which are also
applicable for carbon nanotubes. Moreover, the lateral size of GO affected the
antibacterial activity.262 The larger GO sheets resulted in stronger antibacterial activity
than that of the smaller one, as the larger GO sheets could effectively isolate bacterial
from environment by wrapping the whole bacterium. Recently, the photothermal and
photodynamic effects of graphene-based nanomaterials were also used to kill bacteria
through different pathways.

193, 263

However, all these studies just conducted the

antibacterial activity investigation at the bacterial level, which is based on the common
bacteria such as Escherichia coli and Staphylococcus aureus by evaluating their
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viability. The impact on infection ability of the bacteria treated by GO was not tested.
Meanwhile, the clinical MDR bacteria were seldom used for evaluating the antibacterial
activity of these nanomaterials.
In this work, we used the MDR bacterium, Kp, as a model to investigate the
antibacterial activity of GO. The invasive potency of Kp after treatment with GO was
investigated in both cell culture and animal models. The results indicated that the Kp
treated with GO was effectively killed and the infection ability was dramatically
inhibited in cell culture and animals. To our knowledge, this is the first report studying
the antibacterial property of GO in vivo with a MDR bacterium.

2. Methods and Materials.
2.1 Materials and Instruments.
GO was purchased from Cheap Tubes Inc. (Grafton, VT). Phosphate buffered
saline tablets and fetal bovine serum were purchased from Fisher Scientific (Waltham,
MA). Deionized (DI) water (Millipore Milli-Q grade) with resistivity of 18.2 MΩ•cm
was used in all experiments. C57BL/6J mice were purchased from Charles River (San
Diego, CA). Kp Xen-39 (ATCC 93A 5370), a bioluminescent pathogenic bacterium
strain expressing LUC bioluminescence was purchased from Caliper (Santa Clara, CA).
Kp (ATCC 43816 serotype II) was obtained from Dr. Virginia Miller (University of
North Carolina). Kp Xen-39 (ATCC 93A 5370) was used in the bioluminescene
imaging experiment and Kp (ATCC 43816 serotype II) was used for other infection of
mice. Pseudomonas aeruginosa (Pa) WT PAO1 was a gift from S. Lory (Harvard
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Medical School, Boston, MA). E. coli HB101 strain was obtained from American
Tissue Culture Collection (ATCC). All of the animal experiments were approved by
Institutional Animal Care and Use Committee (IACUC) at the University of North
Dakota.
A Hitachi SU8010 field emission scanning electron microscope was used to
capture SEM and STEM images of GO. A Zetasizer (Marlwen, model of Nano-ZS,
Westborough, MA) was used to measure the Zeta potential of GO. UV-vis absorption
spectra were recorded with a Lambda 1050 UV/VIS/NIR spectrometer (PerkinElmer,
Santa Clara, CA). Luminescence imaging was taken by Caliper’s Xenogen IVIS optical
imaging system (Caliper, PerkinElmer, Santa Clara, CA). The OD value at 560 nm for
3-(4,5-dimethyl-2-thiazolyl)-2,5- diphenyltetrazolium bromide (MTT) and nitroblue
tetrazolium (NBT) assays was measured by a Multiskan spectrum spectrophotometer
(Thermo Scientific, Waltham, MA).
2.2.Antibacterial Activity Tests.
Kp Xen-39 was cultured in Lysogeny broth (LB) medium with shaking at 37
°C overnight before use.264 The next day, the bacterial cells were harvested by
centrifugation and dispersed in PBS with an optical density at 600 nm (OD600) of 0.1
for a concentration of 108 CFU mL-1.265 The samples of GO in PBS were incubated
with bacteria suspension for 2 h at 37 °C. Finally, 100 µL of the bacteria suspension
was added into 900 µL LB medium for the growth in a shaking incubator at 37 °C
overnight. The concentration of bacteria was finally determined by measuring OD600
and the bioluminescence image was taken by IVIS optical imaging system. Meanwhile,
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the plate count method was used to demonstrate the killing effect of GO. Briefly, the
bacteria suspension in LB medium treated with GO was plated on LB-agar plates, and
incubated at 37 °C overnight. The antibacterial activity of GO to E. coli and Pa was
investigated similarly with Kp by changing the bacteria.
2.3.Cell Infection.
The log-phase Kp bacteria (OD600 =1.0) was incubated with different
concentrations of GO (Kp-GO) for 2 h in PBS at 37 °C. The same Kp bacteria without
treatment of GO were used as a control. 0.1 mL Kp-GO and control Kp bacteria were
both diluted with 0.9 mL LB medium for the incubation at 37 °C for overnight. Then,
murine alveolar macrophage (MH-S) cells were infected with control Kp and Kp-GO
for 8 h. MH-S cells were infected by Kp at MOI 10:1 bacteria-cell ratio and then washed
three times with PBS to remove the floating bacteria. Bacteria on the surface of the cells
were killed by adding 100 µL polymyxin B and left in incubation for another 1 h. The
viability of MH-S cells after infection was determined by MTT assay.266 Briefly, 1
µg/ml MTT was added into each well incubated with the infected cells and incubated
at 37°C until color change.267 MTT was reduced to form a purple formazan product
inside living cells. Afterward, stop solution was added to dissolve the formazan product,
and the absorbance was quantified by measuring wavelength of 560 nm using a
spectrometer plate reader.268
2.4.Mouse Infection.
First, the Kp bacteria (OD600 =0.1) were treated with 0.25 mg/mL GO for 2 h
in PBS at 37 °C. The Kp bacteria without treatment of GO were used as a control. For
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in vivo imaging of the bioluminescent Kp Xen-39 in mice, 50 µL GO treated and
untreated Kp Xen-39 were intraperitoneally injected into two groups of mice after
anesthesia with 40 mg/kg ketamine. The bioluminescence images were taken under
IVIS optical imaging system at different time points from 0 to 24 h. The infection level
was semiquantitively evaluated by the bioluminescence intensity determined by the
ROI calculation using the IVIS software.264
For further analysis of the antibacterial efficiency of GO in vivo, the mice
anesthetized with 40 mg/kg ketamine were instilled with GO treated and untreated Kp
by intranasal instillation, and sacrificed when they were moribund. Survival was
determined using Kaplan–Meier curves. After bronchoalveolar lavage (BAL), the lung
was excised for homogenization and fixed in 10% formalin for histological analysis.
The formalin-fixed lung tissue was used for H&E staining to examine tissue damage
post infection.
The viability of alveolar macrophages (AM) was evaluated by MTT assay.
Briefly, the AM cells were obtained from mice infected with GO treated and untreated
Kp. The AM cells in each well were mixed with 1 µg/ml MTT and incubated at 37°C
until color change as above.269 The superoxide anion in AM cell after infection of Kp
was measured by NBT assay. AM cells were grown in serum-containing medium at
37°C for 4 h and then mixed with 1 µg/ml NBT dye for another 1 h. 100 µl of stop
solution (10% DMSO; 10% SDS in 50 mM HEPES buffer) was added into each well
to terminate the reaction. The absorbance at 560 nm was measured using the plate
reader after overnight incubation at 37°C.88
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To evaluate the infection severity of GO-treated Kp in mice, live Kp amounts
in several organs, including the lung, liver, kidneys and spleen were analyzed. The
organs were obtained from the different groups of mice at different time points. Then,
the organs were grounded to determine the amount of intracellular bacteria through
CFU. Briefly, the tissues were homogenized with PBS and spread on LB plates to
enumerate level of bacteria. The plates were cultured in a 37°C incubator overnight,
and colonies were counted. Meanwhile, the amounts of myeloperoxidase (MPO)
released from the four different organs were analyzed by MPO assay. Briefly, the 100
mg/ml tissue samples were homogenized in 50 mM hexadecyltrimethylammonium
bromide, 50 mM KH2PO4, pH 6.0, 0.5 mM EDTA and centrifuged for 15 min at 12,000
rpm at 4°C. Supernatants were decanted, and 100 µL of reaction buffer (0.167 mg/ml
O-dianisidine, 50 mM KH2PO4, pH 6.0, 0.0005% mM H2O2) were added to 100 µL of
sample. After 2 min, the absorbance was read at 460 nm using a spectrometer plate
reader.
2.5. Statistical Analysis.
All experiments were performed in triplicate. Data were showed as mean ±SE
(standard error) from the three independent experiments. All error bars stand for SE.
Group means were compared using Student’s t-test or one-way ANOVA, using
Graphpad Prism 5 software (La Jolla, CA).

3. Results and Discussion.
3.1. Characterization of GO.
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GO was purchased from the commercial company (Cheap Tubes Inc.) and
dispersed into water through ultrasonication to obtain a stable solution. Briefly, 100
mL, 50 µg/mL GO was added with 40 mg NaOH under ultrasonic bath for 3 h to form
stable GO. The resultant GO was purified with 0.1 µm filter. The STEM in Figure 66A
shows that the GO sheet has the size of micrometers. Wrinkles and folds were clearly
observed from the image. Then, the composite of GO was investigated by EDS (Figure
66B), and the presence of carbon and oxygen was identified. The zeta potential of GO
was -45 mV, indicating the presence of the oxygen-containing groups on the surface of
GO (Figure 66C). The large negative charge of GO ensured the stability of GO solution.
Then, UV-vis absorption spectrum was measured to characterize the GO solution. As
shown in Figure 66D, the strong peak at ca. 230 nm was due to the π-plasmon of sp2
carbon structure and the shoulder around 300 nm was ascribed to the n to π* transitions.

Figure 66. Characterization of GO. (A) STEM image of GO. (B) EDS pattern of GO.
(C) The zeta potential of GO. (D) The UV-vis spectrum of GO.
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3.2. Antibacterial Property of GO at the Level of Bacteria.
The antibacterial activity of GO was firstly investigated at the bacterial level
with GO concentrations from 0 to 500.0 µg/mL. The OD600 value and bioluminescence
intensity were measured to determine the concentration of bacteria finally to evaluate
the killing efficiency of GO. As shown in the inset of Figure 67A, the bioluminescence
intensity of Kp (a Kp strain emitting bioluminescence from Caliper) in LB medium
decreased with the increase of GO concentrations. Kp survival rates followed the same
trend as those of the bioluminescence intensity. The survival rates decreased from 100%
to 28.8%, 15.2%, 2.8% and 3.2% when the concentrations of GO increased from 0 to
62.5, 125.0, 250.0 and 500.0 µg/mL, respectively. These results indicated that the
antibacterial activity of GO is concentration-dependent. To further validate the results
from the bioluminescence imaging and detection of OD600, we treated Kp bacteria with
and without GO and determined bacterial colonies using LB-agar dishes. As shown in
Figure 67B, the photographs (a and b) and bioluminescent images (c and d) both
showed that the amounts of colonies drastically decreased treated with 250.0 µg/mL
GO overnight. Collectively, GO exhibited excellent antibacterial activity to MDR Kp
at the bacterial level. To evaluate whether antibacterial activity of GO is ubiquitous, we
also investigated the bactericidal activity in another two bacteria E.coli and P.
aeruginosa (Pa). As shown in Figure 67C and D, GO has the similar antibacterial
activity to E. coli and Pa to Kp. With the increase of the concentration of GO, the
survival rate of E. coli and Pa decreased. However, the survival rate of E. coli and Pa
were 11.8 % and 11.9 % when treated with 250 µg/mL GO (Figure 67C and D), which
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were higher than that to Kp (2.8 %). In order to minimize the effect of high
concentration GO on the animals, Kp was chosen as our model bacterial to investigate
the antibacterial activity of GO in vivo.

Figure 67. Antibacterial property of GO with different concentration. (A) The Kp
survival rate after treatment of different concentrations of GO. Inset: Bioluminescence
images of Kp bacteria after incubation with different concentrations of GO. From left
to right: 0, 62.5, 125.0, 250.0, and 500.0 µg/mL. (B) Representing photographs (a and
b) and bioluminescence images (c and d) of Kp bacterial colonies treated with (a and c)
and without (b and d) GO formed on LB-agar plates. (C) The E.coli survival rate after
treatment of different concentration of GO. (D) The Pa survival rate after treatment of
different concentration of GO.
3.3. GO Increases Host Cells Resistance to Kp.
After the treatment with GO, the infection ability of Kp was investigated in
macrophage cells. MH-S cells were infected by Kp (8 h), which was treated with
different concentrations GO from 0 to 500.0 µg/mL. As shown in Figure 68, using the
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cell without any bacterial infection as the negative control, the cell viability increased
when the concentration of GO increased and reached a plateau around 65 % when the
concentration of GO was 250.0 µg/mL. These results indicated that GO can kill the
bacteria to some extent and inhibit the infection potency of Kp. However, the cell
viability has not recovered to the normal level compared to the cells without treatment.
This might be due to two main reasons. First, GO might have not killed all the Kp
bacteria that would still cause cell death after the infection. Second, GO might have
cytotoxicity that would affect the cell viability at high concentrations. Before GO can
be used in clinics as an antibacterial agent, the biocompatibility should be fully
investigated.

Figure 68. Relative viability of MH-S cells infected by Kp after treatment with different
concentrations of GO (0.0, 62.5, 125.0, 250.0 and 500.0 µg/mL) at 37 °C through MTT
assay.
3.4. GO Increases Resistance to Kp in Mice.

139

We found that GO was able to kill Kp and inhibit its infection potency in cells.
However, the antibacterial activity of GO in the animal level is unexplored. Using a
mouse model, we investigated whether GO treatment can reduce the infection potency
in Kp. To this end, we intraperitoneally injected mice with GO-treated Kp at 1 × 105
CFU (in 50 µL PBS) per mouse. Then, the bioluminescence imaging was carried out
using IVIS Lumina XR system to monitor the invasion and dissemination of Kp in mice.
As shown in Figure 69A, the mouse injected with the Kp without GO treatment showed
diffusing and intense bioluminescence. While bioluminescence stayed in the
enterocoelia cavity in the early time, it extended to the thoracic cavity after 8 h post
injection. However, the dissemination areas and intensity of bioluminescence in mice
infected by GO-treated Kp were more constrained (GO at 250.0 µg/mL). Even after 24
h post injection, the translocation of Kp to thoracic cavity was limited when GO was
used to treat Kp. Then, we semiquantitively measured the bioluminescence intensity in
these two groups (Figure 69B). The bioluminescence intensity of control Kp-infected
mice was almost twice higher (1.6 - 2.0) than that of the mice infected by GO-treated
Kp. This proved that GO was able to kill Kp and inhibit its infection potency in vivo.
Since Kp is a common cause of respiratory infection, we intranasally instilled
Kp in to mouse lungs to investigate whether GO impacts the infection potency. As
shown in Figure 70A, 50% mice died within 48 h with sham- treated Kp, and all the
mice had died at 72 h. In contrast, 80% the mice infected by GO-treated Kp remained
alive during the whole period. The results demonstrated that GO could greatly inhibit
the infection potency of Kp, decreasing the mortality and prolonging the survival of
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infected-mice. After infection via intranasal instillation, the damage of the lung tissue
was also investigated using H&E staining. As shown in Figure 70B, the morphology
was altered, including signs of inflammatory response, tissue damage, and severe
pneumonia in the mice treated Kp without GO incubation. However, GO-treated Kp
caused subdued inflammatory features, reduced polymorphonuclear neutrophil (PMN)
penetration and decreased tissue damage. Therefore, GO can significantly alleviate the
damage of lung tissue by reducing Kp infection ability.

Figure 69. GO decreased infection severity in mice. (A) Bioluminescent images were
obtained using IVIS Lumina XR system at different time points and the mice
intraperitoneally injected with GO-treated Kp and untreated Kp. (B) Semiquantitively
bioluminescence intensity of the two groups in (A).

Figure 70. GO decreased mortality rates and tissue damage. (A) Kaplan-Meier survival
curves were obtained by infecting mice with GO-treated and untreated Kp, respectively
(n=5 mice per group). (B) Morphological evidence of lung injury and inflammatory
responses as assessed by H & E staining histological analysis (20×, scale bar = 50 µm).
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To further delve into the antibacterial mechanism of GO in vivo, the viability
of alveolar macrophages (AM) isolated from the infected mice was evaluated because
AM are a key immune cell in fighting against Gram-negative bacterial infection. The
viability of AM reflects the health state of the bacterial infection. As shown in Figure
71A, the survival of AM in GO-treated Kp infected mice increased by approximately
1.4- and 3.1-fold compared to that of the sham-Kp group at 24 h and 48 h post infection,
respectively. Meanwhile, the phagocyte-derived reactive oxygen species (ROS) is
considered another factor reflecting the extent of bacterial infection. Severe infection
will lead to excessive generation of ROS species (Figure 71B). At 8 h and 24 h post
injection, GO-treatment significantly decreased the generation of ROS in AM,
indicating reduced infection extent. Furthermore, the quantity of PMN in BAL and
blood of the infected mice were also measured to gauge inflammatory response. As
shown in Figure 71C and D, PMN penetration in both BAL fluid and blood of GO
treated-Kp group was lower than that of sham-Kp group at 8 h and 24 h post infection.
Collectively, these data of AM cell viability, ROS species, and PMN penetration
indicated that the infection potency of Kp after GO treatment was greatly dampened in
vivo against the controls.
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Figure 71. (A) Cell viability of AM after bacterial infection by MTT assay. (B) ROS
production in AM cells detected using an NBT assay. (C and D) PMN infiltration in the
BAL and blood was counted by HEMA staining (Thermofisher). ***p < 0.001; RLU:
relative LUC units.
Bacterial spread to various organs is another mortiferous factor during sepsis.
Septicemia and ultimately sepsis might be caused by bacterial dissemination during the
diseases progression. Therefore, we investigated Kp dissemination after intranasal
instillation by determining bacterial burdens in the lung, liver, spleen, and kidneys. As
shown in Figure 72, the lung (A) had the highest bacterial loads, followed by the spleen
(C), kidney (D) and liver (B). However, in all the organs, bacterial CFUs from the mice
infected with GO-treated Kp were significantly lower than those from sham-treated
group at 8 h and 24 h post infection. To validate this observation, we detected the
activity of tissue injury, MPO, in all of the organs as MPO is released from PMN in
response to various pulmonary infections. As shown in Figure 73, in all the four organs,
the activity of MPO followed the same trends as that of the bacterial CFUs in Figure
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72. At 8 h and 24 h post infection, the MPO activity of GO-treated Kp group was
significant lower than that from sham-treated Kp group, indicating lessened infection.

Figure 72. The lung (A), liver (B), spleen (C), and kidneys (D) showed significantly
decreased bacterial burdens in GO-Kp infected mice (Mann Whitney U test). **p <
0.01; ***p < 0.001.

Figure 73. Decreased MPO activity in the lung (A), liver (B), spleen (C), and kidney
(D) of GO-Kp treated mice at 8 h and 24 h. Data are shown as mean + SEM of n = 3
mice per group and are representative of three independent experiments. **p < 0.01;
***p < 0.001; one-way ANOVA (Tukey’s post hoc). RLU: relative LUC units.
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4. Conclusions.
In conclusion, the antibacterial activity of GO to Kp was investigated at the
bacterial, mammalian cell and animal levels in this work. At the bacterial level, GO can
kill Kp in a concentration-dependent manner. More than 95% Kp was killed when the
concentration of GO was at 250.0 µg/mL. After treatment with GO, Kp also showed
reduced infectivity to macrophage MH-S cells, thus increased cell viability. More
importantly, antibacterial activity of GO was investigated in animal models. Similarly,
GO can significantly inhibit the infection potency of Kp after peritoneal injection and
intranasal instillation, respectively. The mortality of mice with Kp infection was
decreased when GO was used. Meanwhile, the inflammatory responses in the lung, liver,
spleen and kidney were also decreased after infected with GO-treated Kp. Taken
together, these findings indicate that GO might be a potential therapeutic agent for Kp,
which may also be used to control other MDR bacteria that cause severe disease in
clinics.
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